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Elevated expression of a membrane protein CD64 on neutrophils is linked with the onset 
of sepsis, a life-threatening syndrome that contributes to millions of deaths annually 
worldwide. The survival rate of septic patients falls rapidly every hour the appropriate 
medication is delayed. Therefore, automated and periodic measurements of CD64 expression 
(nCD64) at the patient’s bedside could lead to timely medical intervention, thereby saving lives 
and billions of dollars. Gold standard assays for measuring nCD64, such as flow cytometry, 
require manual sample preparation and long incubation times. For point-of-care applications, 
however, an assay should be able to measure nCD64 with little to no sample preparation.   
This dissertation addresses the need by investigating portable, point-of-care platforms 
for measuring nCD64 from whole blood without any off-chip sample preparation. Our first 
platform is an electrical biosensor that measures nCD64 by measuring the fraction of 
immunologically captured cells expressing CD64. It consists of a capture chamber, for 
immunologically capturing cells and microfluidic coulter counters at its entrance and exit. In our 
study, we found that the fraction of cells expressing CD64 correlates linearly with nCD64. For 
our study, we optimized the geometry of the capture chamber and the coulter counters from 
the first principles of fluid mechanics and electrostatics respectively. This biosensor can 
produce a readout of nCD64 starting from just 10 μL of blood in 10 mins. Although this 
technique does not require off-chip sample preparation, red blood cells have to be lysed on-
chip so that white blood cells can be counted by the electrical counters. 
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Lysing red blood cells on-chip adds a step which requires multiple pumps running in 
parallel. Ideally, the technique should be able to measure nCD64 without red blood cell lysis. 
Towards that, we have developed an optical, microfluidic cell capture assay that works from 
whole blood. We demonstrate the proof-of-concept of this assay by measuring the density of 
biotin molecules on beads. We injected beads in a capture chamber that is functionalized with 
neutravidin.  Beads that have a higher density of travel, on average, shorter distances in the 
chamber before they get captured compared to the beads with a lower density of biotin. We 
developed a statistical model to extract the probability of capture (ε) per interaction with a 
pillar from the spatial distribution of beads in the channel. ε is found to be linearly proportional 
to the surface density of biotin. 
We expanded this optical technique to measure the nCD64 on neutrophils. One μL 
blood whole blood is injected in a microfluidic channel consisting of a capture chamber 
functionalized with anti-CD64 antibodies. As was the case with beads, the immunologically 
captured have a distinct spatial signature of capture depending on the CD64 expression level. 
Samples with higher CD64 expression travel, on average, a shorter distance in the channel. 
Using the same statistical model used to quantify biotin density on beads, we quantified CD64 
expression on neutrophils. To make this technique easily translatable to a point-of-care device, 
we assembled a smartphone-imaging set-up to replace bulky microscopes. Our smartphone 
microscope can measure CD64 from whole blood without the need for any sample preparation 
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CHAPTER 1: INTRODUCTION 
 
Sepsis is a clinical syndrome defined as a life-threatening organ dysfunction caused by a 
dysregulated host response to infection caused by pathogens like virus, bacteria, and fungi[1]. 
A leading cause of mortality worldwide, sepsis is the most expensive condition treated in 
hospitals in the United States[2, 3], costing the U.S. healthcare system more than $23 billion in 
2013 [4]. Clinical recognition of sepsis is challenging, given and the vast heterogeneity of clinical 
presentation[5]. In the current paradigm, sepsis is defined by evidence of organ dysfunction in 
the setting of presumed infection, but in most cases, early identification is based on the 
recognition of non-specific clinical symptoms. As such, there is currently no single gold standard 
test to diagnose sepsis [6]. Complicating the situation further is the fact that patient condition 
can deteriorate rapidly when the syndrome goes unrecognized. The 72-hour survival probability 
decreases by 7.6% every hour the appropriate medication is delayed [7]. When recognized, 
sepsis is treated with fluid resuscitation, and broad-spectrum antibiotics for the presumed 
bacterial infection and microbial diagnostics such as blood cultures are performed in an 
attempt to grow and identify the inciting pathogen. Not only can it take several days for blood 
cultures to provide definitive results, but 40% of the sepsis patients also test negative for a 
pathogen based on blood cultures [8]. A recent surveillance study of sepsis in U.S. hospitals 
including over 140,000 patients, only 17.2% had positive blood culture results [9].  
Measurement of circulating biomarkers has been proposed as a quick route for 
prognosis, stratification, diagnosis, and monitoring of sepsis [10]. A host of serum proteins like 
C-Reactive Protein, Procalcitonin, Interleukin 6, etc. may be useful to detect sepsis in its early 
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phase[11–13]. Neutrophil activation has also been suggested as a marker for sepsis diagnosis 
and monitoring. Elevated expression of CD64 (nCD64) on neutrophils, for example, has been 
linked to the onset of sepsis[14, 15]. It was reported that neonates suspected of sepsis have 
significantly higher nCD64 compared with controls subjects [16]. A meta-analysis of 26 studies 
including 3944 patients found that nCD64 measurement could lead to early diagnosis of sepsis 
with 76% sensitivity and 85% specificity[15]. Apart from diagnosis sepsis, the nCD64 
measurement could be used to monitor septic patients. It was found that nCD64 declined over 
time in patients receiving appropriate medication, whereas patients who did not receive 
appropriate medication had persistently elevated nCD64 [17]. Therefore, measuring nCD64 at 
the patient bedside could alert the physician about the possible onset of sepsis as well as could 
be used to monitor patient condition once the medication has been prescribed. A host of intra-
cellular mRNA markers have been proposed to be linked to pathways characteristic of sepsis. 
Lukaszewski et al. measured tumor necrosis factor-alpha, FasL, and CCL2 mRNA through real-
time reverse transcriptase PCR in addition to IL-1β, IL-6, IL-8, IL-8 in 92 patients[18]. It was 
found that the combined data could predict the development of sepsis in 83% of cases. To 
study the effect of the transcriptional profile, Sutherland et al. did leucocyte multigene array 
and multiplex-tandem PCT study [19]. They found a panel of 42 gene expression markers that 
played a key role in adaptive immune function and immune modulation pathways. Sepsis was 
predicted with an area under the ROC curve ranging from 86 to 92%. 
However, bulky instruments like flow cytometers and thermocyclers, used to measure 
biomarkers in studies mentioned above, are yet reach at the patient bedside. Moreover, they 
require manual sample preparation which makes frequent biomarker measurement 
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challenging. Microfluidic technologies have emerged as an attractive alternative to existing 
commercial approaches for measuring these biomarkers. 
In Chapter 2, we present an overview of micro/nano technologies for measuring biomarkers 
and pathogens relevant to sepsis.  We describe technologies with special emphasis on those 
that measure cell-surface receptors, physical properties such as motility and deformability, 
RNA/DNA inside the cell, and techniques for pathogen identification such as virus, bacteria, and 
fungi. 
In Chapter 3, we present an electrical biosensor to measure nCD64. Deriving insights 
from numerical simulations, we optimized the geometry of the electrical coulter counter for 
counting White Blood Cells (WBCs). Furthermore, using the first principle of fluid mechanics, we 
analytically derive the most optimal geometry of a microfluidic immuno-capture chamber for 
capturing cells. We combine these two modules to measure the fraction of neutrophils + 
monocytes captured in the immune-capture chamber. It was found that the fraction of cells 
captured in the chamber correlates linearly with nCD64. We extend this technology to measure 
the concentration of IL-6, a plasma protein. 
In Chapter 4, we present a microfluidic technique that can be used to measure antigen 
expression on cells. We demonstrate our approach using biotin-neutravidin as the binding pair. 
We flow beads with varying biotin surface density (mr) through polydimethylsiloxane (PDMS) 
channel with cylindrical pillars functionalized with neutravidin. We analyze how shear stress 
and collision angle, the angle at which the beads collide with the pillars, affect the angular 
location of beads captured on the pillars. We also find that the fraction of captured beads as a 
function of distance (γ) in the channel is affected by mr. Using γ, we extract the probability of 
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capture per collision with the pillar (ε). We show that ε is linearly related to mr, which is 
analogous to the expression level of proteins on cell surfaces.  
In Chapter 5, we extend the technique we developed for measuring nCD64 with a 
smartphone-microscope. In our assay, we inject whole blood into a microfluidic channel to 
immunologically capture neutrophils expressing CD64 along a staggered array of obstacles. We 
capture an image of the channel with a smartphone-microscope to measure the cumulative 
fraction of captured cells (γ) as a function of length in the channel. We fit a statistical model to γ 
to extract the probability of capture of neutrophils per collision with an obstacle (ε), which 
shows a strong correlation with nCD64 measured from flow cytometry. The assay takes less 
than 30 mins to produce nCD64 starting from whole blood samples. We also demonstrate the 
use of our technology to track nCD64 of 8 patients over time admitted to the hospital. In 
summary, we demonstrated a rapid, point-of-care technology for measuring nCD64 that can 
replace the time-consuming and laborious process of flow cytometry for measuring nCD64 in 
neutrophils. Deployment of this technology in ICU could significantly enhance patient care 
worldwide. 
In Chapter 6, we conclude by demonstrating the possible expansion of the smartphone 








CHAPTER 2: MICRO-NANO TECHNOLOGIES FOR BIOMARKER MEASUREMENT AND PATHOGEN 
IDENTIFICATION 
 
Microfluidics refers to the precise manipulation of fluid within channels that are micron 
size in dimension(s)[20]. Physics of fluid flow in such small structures can be different from fluid 
flow in conventional macroscale devices. In microscale devices, the surface area dependent 
forces such as fluidic resistance and surface tension dominate over volume dependent forces 
such as the effect of gravity. The flow of fluid is laminar, and the velocity of suspended cells in 
the fluid is a predictable function of time. This characteristic of flow has been used for sorting 
cells by size [21]. Since the volume of a microfluidic device is small, assays can be done with 
minimal reagents. Microscale devices offer a unique advantage where the entire sequence of 
operation of reagent loading, sample preparation, and analysis can take place in a hands-free 
and automated set-up. Revolution in the semiconductor industry has made possible the 
integration of microscale sensors which can probe such small volumes of analytes [22],[23]. The 
pairing of sensors with microfluidics offers limitless opportunities for cell analysis. Greatly 
reduced reagent cost, the possibility of parallelization and integration with powerful sensors 
has made microfluidics a very promising field in biomedical research [24]. 
Microfluidic Technologies for Quantifying Cell-Surface Receptors 
Although researchers have developed microfluidic devices to characterize and count 
cells based on the specific antigen present on the surface of the cells, relatively fewer reports 
exits that quantify the surface expression of proteins. Zhang et al. reported a technique to 
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measure the expression of CD71 from lysed blood samples[25]. The same group expanded this 
technique to capture highly expressing CD64 neutrophils from the blood of septic patients. The 
capture percentage of cell in septic patients was reported to be significantly higher than that in 
healthy controls[26]. They expanded their technique for multiplex capture of CD25, CD64, and 
CD69 expressing cells in discrete antibody coated regions[27]. The combination of CD64 and 
CD69 improved sepsis diagnosis with the reported area under the ROC curve of 0.98. This 
technique, however, requires manual off-chip RBC lysis and a standard bench-top microscope 
for enumerating the captured cells. Ideally, a point-of-care technique shouldn’t require manual 
sample preparation or costly instruments. 
Cell membrane contains numerous proteins which are essential to the functioning of the 
cell. Some of these proteins are known to be biomarkers for diseases and treatment efficiency. 
For example, the presence of Circulating Tumor Cells (CTCs) in blood over-expressing EpCAM is 
linked to various cancers[28]. CD4+ T cell count of fewer than 200/µL is one of the qualifications 
for a diagnosis of AIDS[29]. Microfluidic devices have a large surface area to volume ratio which 
makes them ideal for immunoassays. Antibodies can be coated on the surface of the devices, 
and cell antigen-antibody interaction can be studied either optically or electrically.  
Cells expressing the surface antigen of interest can be captured in a microchannel by using an 
antibody. The captured cells can then be enumerated by using a microscope[30, 31]. Stott et al. 
developed a microfluidic chip for an efficient immune-capture of CTCs from whole 
blood[32]. These cells are extremely rare (as few as 1 in 109 blood cells) which makes there 
isolation challenging. They designed a chip to facilitate the interaction of the cells with the 
antibody-coated channel (Fig. 2.1a). Forty-five μm tall grooves were patterned on the ceiling of 
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a 50 μm tall channel which promoted cell-antibody interaction by disrupting the streamlines. 
The captured cells were stained with DAPI, PSA (a marker for prostate epithelial cells), and 
CD45 (leukocyte marker), and imaged under a fluorescent microscope. Molecular 
characterization by RT-PCR revealed the presence of TMPRSS2-ERG transcript in lysed CTCs. 
This group has published other microfluidic techniques for CTC isolation and capture from 
whole blood[33, 34]. 
Electrical method of counting cells could require simpler instrumentation as compared 
to optical methods and have been investigated extensively in literature by many groups. 
Change in the impedance of fluid caused by either release of ions from captured cells[35] or a 
distinct electrical signature of an immuno-magnetically modified cell [36] has been used to 
count cells expressing CD4 antigen. In the past, we have reported a microfluidic assay to count 
CD4+ T cells from HIV positive patients. Expanding our previous work on the immune-capture 
assay of CD4+ T cells[37], we developed an automated and hands-free CD4+ T cell counter[38]. 
Briefly, blood entering the chip is depleted of RBCs by chemical lysis (Fig. 2.1b). Lymphocytes 
(and other WBCs) are counted by electrical counters on either side of the chamber where CD4+ 
T cells are selectively captured by antibody-coated pillars. The difference of lymphocyte count 
on the two counters gives the CD4+ T cell count in the blood sample. This chip can count CD4+ T 
cells over three orders of magnitude range (40 to 1000/ µL) very accurately (R2=0.92). 
Besides cell capture techniques which rely on the complete arrest of cells, researchers 
have also developed techniques which exploit transient adhesion of cells to the antibodies. One 
of the earliest attempts dates back to 2004 when Chang et al. reported an on-chip 
'chromatograph' for partial fractionation cells by slowing them down[39]. In this case, Chang et 
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al. report on HL-60 cells, which had an affinity to E-selectin physisorbed in the channel, traveled 
1.5 times slower than U-937 which did not have an affinity to the protein. Similarly, Bose et al. 
utilized transient cellular adhesion of neutrophils to P-selectin molecules to separate them from 
other blood cells[40]. In response to adhesive interactions, neutrophils migrated towards one 
edge of the microchannel where they could be easily isolated whereas cells were pushed by the 
buffer to another side of the channel (Fig. 2.1c). This group has presented a similar technique to 
characterize the rolling behavior of HL60 cells on P-selectin[41] and separate them from K562 
cells[42]. 
Microfluidic Technologies for Measuring Motility and Deformability 
Ellet et al. presented a microfluidic chip to measure the spontaneous motility of 
neutrophils for sepsis diagnosis[43]. It consists of a central region for placing a drop of diluted 
blood (Fig. 2.2a). Neutrophils migrate into a maze of etched channels. A filter, placed before the 
inlets, selectively allows only neutrophils to enter the channel. The spontaneous motion of the 
neutrophils is optically recorded for four hours. A supervised machine-learning algorithm was 
used to identify five key parameters - neutrophil count, some oscillations within a channel, 
pause time between movements, reverse migration out of the channels, and average distance 
traversed by the neutrophils). A sepsis score was created using these parameters which could 
diagnose sepsis in 42 patients with 97% sensitivity and 98% specificity. 
Deformability of a cell can be estimated by (i) Structure-induced deformation where the 
cells are made to pass through a channel smaller than its size[44]. Transit time and elongation 
are some of the parameters that can be optically acquired. (ii) Fluid-induced deformation 
where a stream of fluid is used to generate the mechanical stimuli. 
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Shelby et al. measured the transit time of RBCs through the constriction of a width smaller than 
the size of RBC. It was found that an uninfected 8 micron sized RBC readily traversed the 
channels four times smaller than its size. Whereas a malaria-infected RBC repeatedly failed to 
traverse the channel half its size [45]. Rosenbluth et al. measured the transit time of WBCs 
through microfluidic channels mimicking capillaries. It was found that the transit time of WBCs 
from patients suffering from Acute Myeloid Leukemia with leukostasis symptoms was higher 
that WBCs from patients suffering from Acute Myeloid Leukemia without leukostasis symptoms 
[46]. The throughput of this technique was 50-100 cells/min. Optical systems described above 
suffer from low throughput. To get statistical confidence in the results, Zheng et al. developed 
an electrical system capable of measuring biophysical properties of red blood cells at a 
throughput of 100-150 cells/s. It measured various mechanical and electrical properties of RBCs 
such as transit time through the constriction, impedance amplitude ratio and impedance phase 
increase in response to an AC excitation signal[47]. 
Gossett et al. measured cell deformability by fluid-induced deformation at a single cell 
level at a very high throughput of 2000 cells/s[48]. Cells are lined up by inertial focusing and 
delivered to a hydrodynamic stretching region where cells flowing at high speed meet an 
opposing stream of fluid (Fig. 2.2c). This sudden 'collision' causes the spherical cells to 
deform momentarily into an ellipsoid (Fig. 2.2d). A high-speed camera is used to capture the 
deforming cells and deformability is calculated by taking the ratio of the major axis to the minor 
axis of the ellipsoid. This technique was used to assay leukocytes and malignant cells from 
pleural effusions. It was found that cell deformability could predict disease states in patients 
with immune activation and cancer with up to 91% sensitivity. 
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Microfluidic Technologies for Monitoring Genetic Content Inside the Cell 
The genetic makeup of cells can be determined by digital polymerase chain reaction 
where the cell lysates and genetic material can be compartmentalized into picoliter volumes. If 
each compartment contains at least one copy of the nucleic acid molecule, then amplification 
takes place only in those droplets, and they light up due to the presence of fluorescence 
markers. The fraction of some droplets that light up to total droplets can be used to estimate 
the number of nucleic acid molecules in the starting sample [49]. Often, to gain statistical 
confidence in the results, one has to process tens of microliters of the sample. In such 
situations, generating sufficient droplets by conventional methods, such as cross-flow or co-
flow technique[50], can become prohibitory. Hatch et al. elegantly solved this problem by 
parallelizing droplet generation in a droplet splitter[51]. Each droplet generated by flow 
focusing device split into 256 mono-disperse daughter droplets (Fig. 2.3a). Such a geometry 
allowed for high throughput droplet generation of up to 8 kHz. Using this design, they 
generated over 1-million droplets in 2-7 minutes. In this construct, 10-10000 copies of DNA 
molecules can be analyzed with a detection sensitivity down to 10 copies in 50 µL reaction. 
Conventional methods for nucleic acid amplification rely on bulk assays which do not reveal the 
genetic heterogeneity of a cell population. Studying heterogeneity in a cell population is crucial 
for understanding cellular physiology and identifying targets for therapy. Microfluidics has 
enabled assays where the genetic content of each cell can be determined by performing an 




One such assay was recently developed by Dimov et al. [56]. They developed a system 
that can perform multiplex single-cell RNA cytometry for up to 10,000 cells by carrying out 
parallel 20 pL volume RT-PCR reactions in a microwell array. This system can be applied to 
genes for which antibodies are not available giving it an edge over the conventional flow 
cytometry, and the analysis of a large number of cells per experiment makes the 
experiment/analysis more statistically robust. Interestingly, they showed that for 20 pL volume 
reactions, the end-point fluorescence is proportional to the target DNA in reaction and they 
exploited this to semi-quantitatively reflect the initial amount of nucleic acid target in samples 
(Fig. 2.3b). 
A microfluidic device capable of studying each of the homologous copies of the 
chromosomes has been reported[57]. In this device, a cell in metaphase is microscopically 
identified and isolated from the population. Upon digestion of the cell, the chromosomes are 
randomly separated into 48 partitions where the region of interested is amplified by multiple 
strand displacement reaction. Downstream analysis of the amplicons was used for direct 
observation of recombination events in a family trio and direct measurement of the human 
leukocyte antigen haplotypes — the group built on this technique to reveal de novo mutation 
rates in human sperm[58]. 
Microfluidic Technologies for Detecting Bacteria and Fungi 
Although blood culture is the gold standard for the identification of pathogens in 
hospitals[59], it is a slow process, and it takes up to 5-7 days to report the test results. Time lost 
while waiting for blood culture results adversely affects the timely treatment of the patients 
[60]. Shortening the time to pathogen identification will contribute immensely to the reduction 
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in ICU stay and patient mortality. Lab-on-a-chip devices have shown great promise for rapid and 
automated pathogen identification. They allow for massive parallelization and better process 
control which leads to faster analysis and reduced response times [61]. Since only a few 
microliters of blood are required for their operation (compared to up to 40 ml for blood 
culture), lab-on-a-chip devices can continuously monitor a patient's health. 
Kang et al. describe a culture-free and amplification-free technique that can detect 
bacteria from diluted blood [62]. At the core of their technique is a 3D droplet detection system 
which can detect fluorescence in droplets in rotating cuvette (Fig. 2.4a). Blood is mixed with 
DNAzyme, a molecule which fluoresces upon reaction with lysed bacterial content. The mixture 
is encapsulated in millions of droplets and collected in a cuvette for analysis. The custom 
designed 3D particle counter counts the number of fluorescent droplets in the cuvette. The 
number of fluorescent droplets is a measure of bacteria-count in the starting sample. This 
technique can count bacteria at the single-cell level in 1.5 - 4 hours. Cheng et al. describe one 
such technique for electro-kinetically detecting bacteria in whole blood [63]. When subjected to 
AC, hydrodynamic and electro-kinetic forces act on particles as depicted in Fig. 2.4b. At low 
frequencies, bacteria experience a dielectrophoretic force towards the center of the circular 
electrode, whereas the blood cells are forced out. This concentrates the bacteria a 
thousandfold in a small area of about 5000 µm2 at the center of circular electrodes. The 
concentrated sample of bacteria can then be detected by Surface Enhanced Raman 
Spectroscopy (SERS) based on their unique spectral signature. In a matter of a few minutes, this 
technique can isolate, concentrate, and detect bacteria without the use of an antibody or 
chemical immobilization. Liu et al. present a label-free technique for testing drug-resistant 
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micro-organisms in whole blood[64]. In this technique bacteria (Enterococcus) are selectively 
captured on vancomycin (Van) coated silver-nanoparticle array (Fig. 2.4c). SERS probes the 
captured bacteria. The sub-10-nm gap between silver particles forms 'hot junctions', and 
amplifies the SERS electromagnetic signal. The giant gain in SERS signal (400-500%) enabled 
them to differentiate between the spectral signatures of Van-resistant and Van-susceptible 
strains.  
Amplification-based techniques have been explored to quantify bacteria in physiological 
samples. For example, Wang et al. reported increased sensitivity of bacterial detection by 
targeting abundant transcripts [65]. Hou et al. separated bacteria from RBCs and WBCs using 
Dean drag force in a spiral microfluidic channel [66, 67]. Isolated bacteria were tested for 
antibiotic susceptibility by amplifying their ribosomal DNA. Microfluidic coulter counters have 
become quite popular due to increased sensitivity. Traditionally, the change in the impedance 
caused by a particle while traveling through a pore is measured by an electrical sensor. 
Interestingly, Bernabini et al. reported a micro-impedance cytometer for sizing particles which 
could detect micron size bacteria using transit time as the measured parameter [68]. To 
increase the range of size a coulter counter can measure, Choi et al. reported a device with a 
movable virtual wall of low-conductivity fluid [69]. This width of this movable wall can be 
adjusted according to the size of the particle being probed by varying its flow rate relative to 
the sample. Magnetic techniques have been used in the literature to capture pathogens as well. 
For example, Cooper et al. designed a magnetic concentrator that can spread the fungi-carrying 
magnetic beads in a thin sheet. The thin sheet of magnetic beads enables efficient fluorescence 
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visualization. Using their improved detector design, they were able to detect 20% more C. 
albicans fungi in blood [70]. 
Microfluidic Technologies for Detecting Virus 
Smaller size makes quantification of viruses more challenging compared to bacteria. 
Researchers have to either amplify the genetic content of the virus to detect it or rely on 
indirect methods, such as impedance change upon lysis, for its quantification. Shafiee et al. 
reported a printed, flexible platform for viral load quantification, Epstein-Barr Virus, 
and Kaposi’s Sarcoma-associated Herpes Virus from blood plasma[71]. The virus is 
immunologically captured on the bead surface (Fig. 2.4d). After washing the unbound material, 
the virus is lysed with Triton x-100 to release its contents. The pathogen lysate is injected into a 
flexible plastic microchip where it is electrically probed using electrodes which were printed 
using conductive ink. It was found that the capacitance of the lysate solution is proportional to 
the logarithm of the concentration of virus in the sample down to 100 virus copies per ml of 
blood plasma. To detect virus from whole blood, our lab has demonstrated an impedance-
based approach similar to Shafiee et al. Liposomes were immunologically captured by viruses in 
a chamber. These liposomes released high conductivity fluid upon heat lysis [72]. The 
impedance of the chamber decreased as a result of the ions release which was measured by 
electrical sensors integrated into the chamber. In a separate technique, we demonstrated an 
inexpensive smartphone-based set-up for viral load quantification from whole blood suitable 
for point-of-care setting [73]. Table 1 contains a concise summary of microfluidic technologies 





As mentioned earlier, there is no single biomarker for sepsis. Effective treatment in the 
future would be dependent on the measurement of many different kinds of the biomarker at 
once viz. cell surface receptors, plasma proteins, mRNAs, motility and deformability of cells. The 
objective of the current work is to develop microfluidic techniques for the measurement of cell 
surface receptor CD64 on neutrophils and plasma protein IL-6. In Chapter 2, I will describe my 
contribution to the development of immune-capture technology coupled with on-chip 
cell/bead counting for measuring nCD64 and [IL-6]. In Chapter 3, I will describe an optical 
technique for quantifying the density of biotin on beads which were extended to the 
measurement of nCD64 from a smartphone-imaging set-up. I will conclude by suggesting ways 














FIGURES AND TABLE 
 
Figure 2.1. Microfluidic technologies for characterization of cell surface receptors. a) The figure 
shows a microfluidic channel array for CTC capture from whole blood (top). Figure also shows 
grooves on the ceiling of the channel for introducing vortices in the channel (bottom). b) 
Schematic of the integrated chip showing lysing, quenching, capture and electrical counting of 
cells from a drop of blood. c) Schematic (left) shows the isolation of target cells from whole 
blood by affinity flow fractionation. Strips of gold (right) patterned with P-selectin that allow 




Figure 2.2. Microfluidic technologies for characterization of physical properties of the cell a) 
Figure showing the microfluidic chamber with loading chamber and four mazes b) Three 
migration patterns of neutrophils from a sepsis sample in a maze of microfluidic channels c) 
Schematic of the microfluidic that focuses cells to the channel centerline by inertial focusing d) 




Figure 2.3. Microfluidic technologies for quantifying genetic information inside the cell. a) The 
figure shows a massively parallel generation of picoliter-sized droplets by a microfluidic splitter 
b) Endpoint fluorescence of cells inside 20 pL microwells is proportional to the log of the initial 




Figure 2.4. Micro-Nano technologies for pathogen identification in blood. a) Digital Detection of 
Droplets. DNAzyme fluoresces when it reacts with bacterial contents. Droplets are collected in a 
rotating cuvette for counting fluorescent droplets b) Electrokinetic Concentration and SERS 
Detection of Bacteria. In response to AC bacteria are concentrated in a small area close to the 
center of the circular, whereas the blood cells are forced out. Concentrated bacteria are 
detected by Surface Enhanced Raman Spectroscopy (SERS) c) Detecting Van-resistant Bacteria. 
Bacteria are captured on a silver nanoparticle array by Vancomycin (Van). The giant gain in the 
SERS signal by “hot junctions” between silver nanoparticles enables differentiation of Van-
resistant and Van-susceptible bacteria d) Flexible Sensor for Viral Load Quantification. Virus are 
capture immunologically captured on a bead (i), washed (ii), lysed to release its contents (iii), 
and the capacitance of the lysate solution is measured in a flexible channel with electrodes 





Pathogen Sensing Modality Sample Type Limit of 
Detection 
Reference 
Bacteria (E.coli) Optical 
(Fluorescence) 


















One Bacterium 65 
Bacteria 










Growth media - 68 
Bacteria 
(E.coli, F. tularensis) 
Electrical 
(Impedance) 
















Growth Media < 1  cell/ml 70 









6.7 x 1013/ml 72 




6.7 x 105/ml 73 
 
Table 2.1. Microfluidic technologies for detecting virus and bacteria from blood. Mode of detection, 















CHAPTER 3: ELECTRICAL BIOSENSOR FOR MEASURING nCD64 AND [IL-6] 
 
INTRODUCTION 
In this chapter, we present an electrical biosensor that can be used to measure nCD64 
on white blood cells and [IL-6] from human plasma. In this assay, we inject ten μL whole blood 
in the chip. First, the red blood cells are selective lysed using a lysing buffer. Then, to halt the 
lysis, we inject a quenching to preserve the white blood cells. The white blood cells are counted 
using an on-chip coulter counter. The white blood cells enter a microfluidic capture chamber 
where the cells expressing CD64 are captured. The remaining cells are counted by another on-
chip counter on their way out. We show that the fraction of cells captured in the capture 
chamber increases linearly with the expression of CD64 on the cells. This work was published in 
Nature Communications in 2017 with Dr. Umer Hassan as the first author  [74]. We extend this 
technology of particle capture to measure [IL-6] in human plasma, where the fraction of beads 
captured in the capture chamber correlated linearly with [IL-6] in the sample. This work was 
published in Lab on a Chip in 2018  with Dr. Enrique Valera as the first author [75]. For this 
assay, using numerical simulations, we optimized the on-chip counter. We solved the Laplace’s 
equation for the electric potential in a charge-free space, to determine electrode geometry that 
led to a higher quality electrical signal from beads and cells. Moreover, working from the first 
principle of fluid mechanics, we found out the optimum geometry of the capture chamber that 
led to a decrease in non-specific capture of cells. For measuring CD64 expression and [IL-6], I 
collaborated with Dr. Umer Hassan and Dr. Enrique Valera, respectively. 
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MATERIALS AND METHODS 
Microfluidic Impedance Cytometry Set-up 
Microfluidic Impedance Flow Cytometry is used to detect particles in a fluid [76]. As a 
particle flows over the electrodes energized by an alternating voltage, it causes a momentary 
change in the impedance of the region between the electrodes (Fig. 3.1a). The counter detects 
these changes in the impedance. The change in the resistive part of the impedance is 
proportional to the volume of the cell. So, the amplitude of the signal is proportional to the 
size. The imaginary component of the electrical signal gives us information about cell-
membrane capacitance which can be used to differentiate similar sized white blood cells having 
different membrane properties. In the literature, it has been used to count lymphocytes, 
monocytes, and neutrophils from lysed or diluted blood [38, 77]. 
The process flow for acquiring an electrical signal from particles is depicted in Fig. 3.1. 
Beads/cells flow over electrodes connected to a lock-in amplifier supplying an AC signal at 303 
kHz (1 V peak-to-peak). Current flowing between the electrodes is fed to a current amplifier 
(Zurich Instruments, Switzerland) to boost the signal-to-noise ratio (Fig. 3.1b). The output from 
this instrument is fed back to the lock-in amplifier to extract the signal. Noise-free data 
generated at this step is recorded at 50 kHz (beads) or 250 kHz (cells) by PCI-6351 DAQ  card 
(National Instruments, Austin, TX) (Fig. 3.1c). Data is visualized during the experiment and 





Simulating Electric Field in the Electrodes 
Two electrode geometries were tested for counting particles. The first geometry 
consisted of 15 µm electrodes separated by 15 µm (Fig. 2.2a). The second geometry consisted 
of 100 µm electrodes separated by 150 µm. We numerically calculated the electric field (E) 
along the vertical line that bisects the line joining the electrodes. To calculate E, we numerically 
solved Laplace's equation (assuming charge-free space) to calculate potential (V) first:  
2 0V =                     (1) 
The electric field, E, is given by the equation: 
E V= −                                 (2) 
This equation was solved in the rectangular region containing the electrodes. The 
central electrode was set at potential V = 1 Volt; The other two electrodes were grounded. The 
bounding rectangle was set as the insulating boundary. 
Simulating Fluid Flow  
The streamlines in the capture chamber were generated by solving Navier-Stokes for 
water in COMSOL. No-slip boundary condition was set at all the boundaries except at the inlet 
and the outlet. The flow domain is discretized using triangular mesh elements. A grid-size-
independence study is performed by progressively refining the mesh grid size until the 
computed results is less than 0.1%. A convergence criterion for the numerical simulations is 




Analytically Determining Optimum Inter-Pillar Gap 
Fig. 2.3 shows the schematic of the capture chamber. Each row of pillars is shifted 
concerning the previous row such that the 4th row is situated directly under the 1st row. Such 
an arrangement gives rise to a cyclic design where the unit of repetition is three rows. The 
motion of flow streams, which are streams carrying an equal volume of fluid, is also cyclic 
having the same unit of repetition, viz. Three rows. In such cyclic geometry the flux of fluid 
though each gap can be divided into three flow streams each carrying an equal volume of fluid. 
These flow streams shift their position cyclically just like the row of pillars such that after 3 rows 
each flow stream returns to its original location. The average speed of the fluid flowing in these 
streams also changes cyclically. The fluid stream closest to the pillars (stream 1 and stream 3) is 
slower than stream 2. There is a cyclic change in the speed of the flow streams. This ensures 
that each flow stream flows at the speed when averaged over three rows. This causes the 
motion of particles in the speed modulation region to be cyclic as well. In such a cyclic design 
the underlying physics requires that the size of the particles be in a certain range for them to 
collide with the pillars and while still travel in a first-in-first-out fashion. When the radius of the 
particle is less than β, the width of the first flow stream, it travels with a flow stream. This 
causes the average speed of the particle to be constant when averaged over three rows. 
However, the particle has to be at least as large as the width of the first flow stream, β, for it to 
even make contact with pillars. If the particle is smaller than β than it might not have a chance 
to interact with the antibodies coated on the pillars. This defeats the purpose of having pillars 
in the speed modulation region. One can tweak the geometry of the pillars to suit the size of 
particles that are injected in the channel. For diameter, d, between the pillars the size of the 
26 
 
particles should be between a minimum gap (gmin) and a maximum gap (gmax) for them to have 
consistent dwell-time and interact with antibodies as well. And one can tweak that gap while 
fabricating the channel to suit the size of the particles that are flowing. The equation relating g 









                                           (3) 
where correct cube root of unity, w, is given as follows 




= −   
Electrode Fabrication 
The fabrication of electrodes is done by a standard lift-off technique. The recipe used 
here is as follows.  
1) Degrease the wafer (acetone, IPA, DI, IPA, N2 dry) 
2) Descum 1 min at 100 W O2 plasma 
3) Spin coat AP8000 adhesion promoter (3000rpm, 30sec) 
4) Spin coat top side of the wafer with SPR 220 (3000rpm, 30sec) 
5) Soft bake on Al ring 2 minutes at 60oC and 1 minute at 110ºC 
6) Expose with Energy set as 210 mJ/cm2 
7) Develop in AZ400K developer (5: 1:: DI: Developer, 100ml DI) about 1-2 minutes 
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8) DI quench then rinse with low-pressure DI, N2 dry 
9) Check with a microscope for developing result 
10) Hardbake 30 sec at 110ºC 
11) Sputter 50 Å Titanium as the seed layer 
12) Sputter 700 Å Gold  
13) Liftoff in 1165 PR stripper in ultrasound for 5-10 minutes and rinse with DI water 
The wafer is diced into individual counters using a dicing saw. 
SU-8 Mold Fabrication 
The SU-8 mold for making PDMS channels was fabricated using standard 
photolithography techniques. Briefly, SU-8 50 (Microchem) was spun at 2000 rpm for 30 s. After 
soft-baking the wafer at the recommended temperature and duration, SU-8 was exposed with 
UV light at a dose of 450 mJ/cm2. After baking the wafer at the recommended temperature and 
duration, unexposed SU-8 was washed away by developing the wafer in SU-8 developer 
(Microchem). The wafer was hard baked at 150oC for 10 min on a hotplate. The thickness of the 
SU-8 structure was measured using a surface profilometer (Alpha-Step D-500 Stylus 
Profilometer, KLA Tencor) to be 65 μm. 
Making PDMS Devices from the Mold 
The sensors are gold or platinum electrodes which are patterned on a glass substrate by 
a standard photolithographic technique. To record a high-quality measurement of cells, the 
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sensors must be precisely aligned with the microchannels to the micrometer. For this to be 
possible, the PDMS device must have a uniform thickness. This allows the surface of the PDMS 
to come into complete contact with the substrate all at once when using an aligner, minimizing 
relative motion between the PDMS and substrate. Without proper alignment between the 
electrode and the microchannel, the microchannel can lose complete functionality. Step by step 
procedure for obtaining a constant thickness of PDMS is outlined below: 
Bond the mold to a 5” silicon carrier wafer - Using heat resistant gloves, pick up the 
carrier wafer and place it on a hot plate set to 200oC. Then, rub the glue stick on the wafer (glue 
will melt and stick onto the wafer), creating a thin layer with a diameter of two to three inches. 
Then, Place the mold on top of the larger wafer. Press the mold down gently to eliminate any 
air bubbles between the wafers. Turn off the hot plate. Wait 30 minutes for the wafers to fully 
bond together. 
Form an aluminum foil boat on the silicon carrier wafer - Cut out a large piece of 
aluminum foil that is 3 inches larger than the carrier wafer on all sides. Lay the aluminum foil 
down on a clean surface. Place the carrier wafer on top of the aluminum foil, with the mold 
facing up. Begin folding the edges of the aluminum foil up to create clean creases against the 
edges of the carrier-wafer. Be careful not to tear the aluminum foil at any sharp edges. There 
cannot be any holes. Press down the edges of the aluminum foil while folding back the top. Use 
your thumb to hold down the bottom of the foil while folding the top back. The foil should be at 
least 5 mm away from any part of the mold’s pattern. Try not to touch the surface of the mold 
during this step. Press down the edges to form the walls of the boat.  
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Cure PDMS in the aluminum boat - Mix the curing agent to PDMS in a 1:10 ratio. Rapidly 
mix the mixture for 5 minutes. Pour the mixture into the aluminum boat. Degas the fluid in a 
desiccator. Place the hot plate onto the hot plate leveler. Use a Torpedo level to check if the 
hot-plate is entirely balanced. Turn the hot plate to 95oC. Place the aluminum boat on the hot 
plate and wait for the PDMS to harden. This should take at least 45 minutes. Turn off the hot 
plate and wait 15 minutes for the PDMS to cool. Cut out the hardened PDMS and place it 
pattern-side-up in a clean petri dish.  
The carrier wafer allows for a larger area around the pattern of the mold. Therefore, 
when one cuts the PDMS off the wafer, there is less of a likelihood of cutting too close to the 
pattern and damaging it. Also, the level of the PDMS can differ with every batch. Having more 
space off of the pattern allows for any potential sloping to not affect the actual microchannel. 
Use the smooth aluminum boat (with the bottom of the carrier wafer exposed), hot plate 
leveler, and Torpedo level for every batch of PDMS. Recreate the aluminum boat as often as 
needed. Using all the proper materials will ensure uniform thickness in all the devices produced 
thus making alignment much easier and more successful. 
The microfluidic channel thus produced can be bonded to the electrodes by oxygen 
plasma bonding. 
On-Chip Bead and White Blood Cell Counting 
7 µm beads (Product #TP-60-5, Bangs Labs)in PBS was injected using Syringe pumps (Harvard 
Biosciences) at five μL/min. The electrical signal of the beads was acquired through the 
electrical set-up described above. A custom MATLAB code was written to filter out unwanted 
frequencies and measure the amplitude of the signal.  
30 
 
Blood from consenting patients was collected in an EDTA tube. Blood samples were de-
identified and stored in a refrigerator until they were ready to be run on our chip. 10 ul blood 
was loaded on a syringe and injected in the lysing chip. The lysing chamber height was varied 
such that the total lysing time for a flow rate of 1 μL/min, 2 μL/min and 3 μL/min was constant 
[74]. The WBCs were counted using the electrical set-up. 
On-Chip nCD64 Measurement and WBC Counting 
We measured nCD64 on Granulocyte + Monocyte in whole blood using our differential 
capture immune-affinity capture assay [74]. Briefly, 10 μL blood is injected at 1 μL /min. The red 
blood cells are lysed by mixing lysing reagent (s 0.12% Formic acid (v/v) and 0.05% Saponin 
(w/v) in DI water) with blood. To halt the lysing process, the blood was mixed with quenching 
agent (21.1785% 10 PBS (v/v) and 0.57525% sodium carbonate (w/v) in DI water). The 
leukocytes in the debris free solution are counted before they enter the capture chamber. The 
capture chamber is functionalized with the anti-CD64 antibody. Granulocyte + monocyte 
expressing CD64 are immunologically captured in the capture chamber. After that, the 
remaining granulocyte + monocyte are counted at the exit counter. 
Measuring [IL-6] with the Differential Counting Technology 
We extended our differential counting technology to measure [IL-6] from plasma 
samples [75]. 10 μL plasma was mixed with ~2500 beads which were functionalized with the 
anti-IL-6 antibody. The mixture was incubated off-chip for 2 hours at room temperature. Then, 
a 5 μg/ml solution of secondary, biotinylated anti-IL-6 antibody was added to the mixture and 
incubated for 30 mins at room temperature. The complex was washed with PBS, and the beads 
31 
 
were suspended in 150 μL 1x PBS solution. The bead-Ab1-IL-6-Ab2Biotin complex was injected 
in a chamber functionalized with streptavidin. The fraction of beads captured in the chamber 
was measured through the microfluidic impedance cytometry set-up described earlier. 
RESULTS AND DISCUSSION 
Increasing Distance between the Electrodes Makes Electric Field Homogeneous 
We numerically calculated the electric field at the center line between the two 
electrodes by solving the Laplace's equation. Fig. 3.2e shows the Electric Field (E) plotted 
against the distance from the floor of the channel. For the geometry with w=15 µm, d=15 µm, 
the electric field is not uniform across the cross-section. The electric field increases from 0.05 
V/m near the electrodes to 0.028 V/m at near the ceiling of the 15 µm tall microfluidic channel. 
For the geometry with w=100 µm, d=150 µm, the electric field is uniform across the cross-
section. Since the electric field is uniform, the amplitude of the voltage signal will be 
independent of the vertical location of the particle in the channel.  
Standard Deviation of Signal Amplitude of Two Electrode Geometries 
We compared the standard deviation of the signal amplitude of two geometries in our 
study. We did so by injecting seven μm beads at 5 μL /min in the channel. The amplitude 
histogram from the two geometries is plotted in Fig. 3.4a and Fig. 3.4b. Notice that for the same 
beads, the signal from the geometry with w=d=15 μm has a standard deviation of more than 
ten times that for the geometry with w=100 μm, d=150 μm. This is a direct consequence of the 
fact that the electric field for geometry with w=100 μm, d=150 μm homogenous across the 
cross-section (Fig. 3.2e). Because the electric field is homogeneous, the change in current is 
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independent of the vertical location of the particle. The standard deviation from three 
independent experiments is compared in Fig. 3.4c. All the results henceforth were obtained 
using this new geometry of electrodes. 
Resolution Testing 
We tested the optimized geometry of electrodes for its size discrimination ability. This is 
an important test since this electrode was eventually used to distinguish between white blood 
cells by size. We injected 5.5 μm and 7 μm beads. The amplitude histogram of the electrical 
signal is plotted in Fig. 3.5. We can see two populations in the histogram which corresponds to 
two the different bead populations. Hence, the new geometry can distinguish between two 
closely sized beads. 
On-chip Granulocyte + Monocyte Counting 
We counted granulocyte + monocyte in patient samples using our technology. Fig. 3.6b 
shows the amplitude histogram of all WBCs in the sample. There are two subpopulations in the 
histogram. Lymphocytes, the smaller white blood cells, are on the left. Granulocyte + 
monocyte, the larger white blood cell types, are on the right. Granulocytes and monocytes 
cannot be differentiated from one another by size alone. After putting appropriate thresholds, 
we counted granulocytes + monocytes in n=181 samples using our technology (Fig. 3.6c). We 





Optimizing the Capture Chamber Geometry 
Immuno-capture of cells takes place in the capture chamber. The pillars in the capture 
chamber, functionalized with a suitable antibody, act as sticky obstacles in the path of the cells. 
It is important that the dwell-time, the time a cell spends in contact with pillars, be the same 
across all cells to ensure that the probability of capture is uniform. Supplementary movie 1 
shows the beads flowing in a capture chamber with row-shift-fraction = 0.5. Some beads that 
collide with the pillar at the region of zero velocity (Fig. 3.7) spends a considerably longer time 
in contact with the pillar. This would lead to an increased probability of capture for these 
beads. To ensure that the dwell time of beads is uniform, we changed the row-shift-fraction to 
0.33. In such a geometry there are no dead-spots, and all the beads are expected to have 
similar dwell-time on the pillars, irrespective of their position in the channel. But for a geometry 
with row-shift-fraction = 0.33, the gap (g) between the pillars has to selected such that the 
beads travel straight while also periodically touching the pillars. We obtain gmin in, and gmax 
from equation 3. gmin in and gmax are plotted in Fig. 3.8. For beads d = 7 µm, so we selected g = 
17 µm. The motion of beads in such a geometry is shown in Supplementary movie 2. All the 
beads have similar dwell time on the pillars irrespective of their position in the channel. g = 18 
μm will also ensure that granulocyte and monocytes, which have size 10-12 μm, have uniform 
dwell time in all the cells. We compared the non-specific capture of cells in the two capture 
geometries. The chambers were blocked with 1% BSA for 1 hour before the experiment. The 
fraction of cells captured in the chamber was calculated using two electrical counters, one at 
the entrance and the other at the exit of the chamber. The non-specific capture in the 
geometry with row-shift-fraction = 0.5 is higher compared to the geometry with row-shift-
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fraction = 0.33 (Fig. 3.9). We attribute the reduction of the non-specific capture to the 
elimination of dead-spots in the geometry. 
Tracking nCD64 and WBC Count in Patients 
We ran n=102 samples through our biochip and nCD64 and WBC count in patients. We 
plot percent granulocyte + monocyte capture Vs. control nCD64 expression in Fig. 3.10a. 
Percent of granulocyte + monocyte increases linearly with an increase in nCD64. The coefficient 
of correlation is 0.87. To obtain nCD64 values from our biochip measurements, we performed 
threefold cross-validation with 1000 random sample generation on the percentage granulocyte 
+ monocyte capture. The nCD64 value thus obtained is plotted in Fig. 3.10b. Bland-Altman chart 
(Fig. 3.10c) of this data shows that there is good agreement between the biochip measurement 
and control measurement across the entire range of nCD64. nCD64 and WBC count were 
tracked in a total of 91 patients (Fig. 3.10d). nCD64 and WBC count measured from the biochip 
in individual patients in Fig. 3.10e. 
Measuring [IL-6] in Human Plasma 
We measured [IL-6] in from n= 29 human plasma sample through the differential 
counter technology. Fig. 3.11b shows the standard curve of percent capture vs. control [Il-6] 
measurements. We can measure [Il-6] from 127 pg/mL to 5000 pg/mL. Key experimental 
parameters are listed in Fig. 2.11c. We used this standard curve to measure [IL-6] from patient 
samples (Fig. 3.11d). There is a high coefficient of correlation between our measurement and 
control measurement (R2= 0.81, y = 1.01x). The bland-altman chart shows that [IL-6] measured 
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from the capture technology is in good agreement with control measurements, especially for 
[IL-6] < 6000 pg mL-1.  
CONCLUSION 
We presented an electrical biosensor that can be used to measure the nCD64 on white blood 
cells and [IL-6] in human plasma. We first optimized the geometry of the electrical coulter 
counter by numerical simulations. Then, we solved the Navier-Stokes equation under certain 
assumptions to find out an optimum gap between pillars such that the beads travel predictably 
and its trajectory repeats every three rows. We combined the two modules to measure nCD64 
from patient samples acquired from Carle Hospital in Urbana, IL. We found that the fraction of 


















Figure 3.1. Signal Acquisition Set-up. a) Current flowing between the electrodes is converted to 
a voltage signal by a current-to-voltage amplifier. Adapted from [79] b) The signal is fed to a 
lock-in-amplifier where it is demodulated c) The real imaginary component of the signal are 
acquired via a DAQ d) The signal is visualized through LabVIEW and stored on a local PC for 




Figure 3.2. Comparing Electric Field in Two Geometries of Electrical Sensors a) Microscopic 
image of the electrodes with w = d = 15 µm. Adapted from [38]. Scale bar: 45 µm b) Schematic 
showing the electric field lines across a cross-section of electrodes in a) c) Microscopic image of 
the electrodes with w = 100 µm, d = 150 µm. Adapted from [75]. d) Schematic showing the 
electric field lines across a cross-section of electrodes in a) e) Plot compares the electric field 
along a line equidistant from the two electrodes (along with the dotted vertical lines in b) and 
d)). The electric field is homogenous in the geometry with w = 100 µm, d = 150 µm. It varies 






Figure 3.3. The figure shows the top view of streamlines in a capture chamber. Each row is 
shifted to the right by a third of the distance between two pillars in the same row. Streamlines 
cyclically permute in the gap between the pillars. Such a cyclic permutation gives rise to a cyclic 





Figure 3.4. Comparing the Standard Deviation of Signal of Two Electrode Geometries a) Figure 
shows the size histogram of 7 µm beads detected by the electrode geometry with w = d = 15 
µm b) Figure shows the size histogram of 7 µm beads detected by the electrode geometry with 
w = 100 µm, d = 150 µm c) Bar plot compares the standard deviation of signal acquired through 
two geometries. The standard deviation of the signal acquired through the geometry with w = 
100 µm, d = 150 µm is more than 10 times smaller than that acquired through the geometry 






Figure 3.5. Amplitude histogram of two closely sized beads acquired through the electrodes 
with w = 100 µm, d = 150 µm. This geometry of electrodes can distinguish between 5.5 µm and 




Figure 3.6. On-chip WBC Counting a) Schematic shows the process of counting WBCs on-chip. 
10 µL blood is injected along with lysing and quenching buffers to lyse RBCs. WBCs that are left 
in the suspension are counted with the microfabricated electrodes b) Amplitude histogram of 
showing WBC subpopulations detected by the microfabricated electrodes c) Plot compares the 
granulocyte + monocyte counted on-chip using microfabricated counters to that counted using 





Figure 3.7. The figure shows streamlines in the capture chamber with a row shift fraction = 0.5. 




Figure 3.8. The plot shows the maximum gap (gmax) and minimum gap (gmin) between two 
pillars in a row as a function of the diameter of the particle (d) that leads to dwell-time 




Figure 3.9. Box plot compares the non-specific capture of cells in two capture geometries 
tested in our study. Capture chamber with row-shift-fraction = 0.33 has significantly lower non-





Figure 3.10. Measuring nCD64 and WBCs from Patient Samples a) Plot shows the percentage 
capture of neutrophils + monocyte versus nCD64 measured by flow cytometry for n=102 
samples b) Plot shows the nCD64 measured from biochip versus nCD64 measured by flow 
cytometry for n=102 samples c) Bland-Altman analysis chart. It shows nCD64 measurements 
from the biochip are in close agreement for values of nCD64 d) Plot shows WBC count and 
measured nCD64 from the biochip as a function of patient admission time e) Plot shows WBC 
count and measured nCD64 tracked for individual patients during their stay in the hospital. 




Figure 3.11. Measuring [IL-6] in Plasma from Patient Samples a) Experimental sequence for 
measuring [IL-6]. Blood is centrifuged to extract plasma. The plasma is incubated with beads 
off-chip conjugated with a primary antibody to capture IL-6. After magnetically separating 
beads, the beads are incubated with secondary, biotinylated antibody. Beads are injected in a 
chamber functionalized with streptavidin. The fraction of beads captured is measured with 
electrical sensors b) Calibration curve shows percentage capture versus [IL-6] c) Table shows 
the important metrics of the curve in b) d) Plot shows the [IL-6] measured from captured 
technology versus control measurements e) Bland-Altman analysis chart. It shows that [IL-6] 
measured from the capture technology is in good agreement with control measurements, 




CHAPTER 4: OPTICAL TECHNIQUE FOR MEASURING BIOTIN DENSITY ON BEADS 
 
INTRODUCTION 
Antigen expression is an important biomarker for cell analysis and disease diagnosis. 
Traditionally, antigen expression is measured in a flow cytometer which, due to its cost and 
labor-intensive sample preparation, is unsuitable to be used at the point-of-care. Therefore, an 
automatic, miniaturized assay which can measure antigen expression near the patient could aid 
crucial clinical decisions to be made rapidly. Such a device would also expand the use of such an 
assay in basic research in biology. In this chapter, we present a microfluidic device that can be 
used to measure antigen expression on cells. We demonstrate our approach using biotin-
neutravidin as the binding pair using experimental and computational approaches. We flow 
beads with varying biotin surface density (mr) through a polydimethylsiloxane (PDMS) channel 
with cylindrical pillars functionalized with neutravidin. We analyze how shear stress and 
collision angle, the angle at which the beads collide with the pillars, affect the angular location 
of beads captured on the pillars. We also find that the fraction of captured beads as a function 
of distance (γ) in the channel is affected by mr. Using γ, we extract the probability of capture 
per collision with the pillar (ε). We show that ε is linearly related to mr, which is analogous to 
the expression level of proteins on cell surfaces. The results presented in this chapter are based 
on our published work in APL Bioengineering [80]. 
The schematic of the microfluidic channel used for the experiment is shown in Fig. 4.1a, 
and an optical image of the fabricated devices shown in Fig. 4.1b, c. Beads are injected from 
port A at 1 µl/min. We tested 6 populations of beads with a varying surface density of biotin 
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(mr). To ensure that beads experience consistent shear stress, buffer from ports B, C1, C2, D1, 
and D2 hydrodynamically focuses the beads in the channel[81]. At the end of the experiment, 
microfluidic channels are imaged under a microscope. Coordinates of the captured beads are 
extracted using a custom written macro in FIJI (See Materials and Methods for details). 
MATERIALS AND METHODS 
Theoretical Model for Bead Capture 
The equation that governs the probability of particle capture, P, mediated by bond 
formation between receptors and ligands has the form[82] 
( / n)r l c aP m m A K f=                     (4) 
where mr is the surface density of receptors (biotin), ml is the surface density of ligands 
(neutravidin), Ac is the area of interaction between the biotinylated bead, and the neutravidin 
coated pillar, and Ka(f/n) is the binding affinity. It is equal to the ratio of forward and reverse 
rate coefficients for formation and breakage of the nth bond, respectively. This equation has 
been used in the literature to estimate the probability of capture.[83] It is assumed that the 
dislodging force, f, is equally shared by n bonds, where n is the smaller of the number of 
molecules available on two surfaces for bond formation, i.e., n = min (Acmr, Acml). In this 
experiment ml is less than mr. So, n can be replaced by Acml in the above equation. This 
equation predicts that the probability of adhesion increases linearly with receptor density (mr). 





If we assume that the downstream distance between consecutive pillars that a bead collides 
with is Δx (Fig. 4.2), and the chance of capture per encounter with a pillar is ε. Then, a bead will 
encounter x/Δx pillars in a distance x, and the probability of capture γ can be expressed as 
γ = 1 - (1- ε) x/Δx           (5) 
(probability of no capture on n encounters is (1- ε)n, and subtracting it from 1 gives the 
probability of capture, here n = x/ Δx). This model, however, does not take into account bead-
bead interaction. Through our experiments, we will acquire γ as a function of x. After that, we 
fit the experimental data to this model to estimate ε. ε is expected to be linearly related to mr 
(Equation 5).  
Biotinylated Bead Synthesis and Surface Density Quantification 
Beads with a varying surface density of biotin were prepared by linking Amine-PEG2-
Biotin to Carboxylate Modified Latex beads via standard EDC-NHS chemistry. The step-wise 
schematic for preparing the beads is shown in Fig. 4.3a. The full protocol is given below. 
Materials: 
1. CML Latex Beads 4% w/v, 7µm (Cat # C37257, ThermoFisher). 
2. Amine-PEG2-Biotin (Thermofisher, Catalog Number 21346) 
3. 2-(N-Morpholino)ethane sulfonic acid (MES). 
4. EDC (Thermofisher, Catalog #22980). 
5. NHS (Thermofisher, Catalog #24500) 




Buffers and solutions: 
1. Wash and coupling buffer: 100mM MES. Store the stock at 4ºC. 
a) Dissolve 2.067 g MES in water (25 mL); 
b) Adjust to pH 6; 
c) Furring with water to 50mL. 
2. Conjugation buffer: 10 mM PBS, pH 7.4. Store the stock at 4ºC.  
3. Blocking buffer: 750 µg/mL Glycine (10 mM PBS). Store the stock at 4ºC. 
4. Filtered beads:  
a) Vortex (30”) the stock of latex beads. 
b) Transfer 1mL to a 1.5mL Eppendorf tube. 
c) Sonicate (10”) the tube. 
d) Filter the solution (10 µm porous filter).  
e) Transfer the filtered solution (~ 0.8 mL) to a new 1.5mL Eppendorf tube. Use 
parafilm to seal the tube. Store the stock at 4ºC. 
Procedure: 
1. Vortex the filtered beads. 
2. Transfer 0.25 mL to a 1.5mL Eppendorf tube. 
3. Add 1 mL of wash buffer. 
4. Spin down the solution (15000 g, 10 min). 
5. Aspirate and discard the supernatant. 
6. Repeat 3 – 5 (2 times). 
7. During the last spin prepare 100 mM EDC (19.15 mg/mL) and 50 mM NHS (5.8 mg/mL). 
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a. Weight around 1 mg (EDC) and 0.3 mg (NHS). 
b. First, resuspend (in coupling buffer) the reagent who requires more volume. 
c. Use the solution from b) to resuspend the other reagent. Minimum volume 
required = 10 µL. 
8. Resuspend the dry beads from 7) in 90 µL MES. 
9. Add 10 µL of the solution from 8). EDC final concentration = 10 mM. 
10. Seal the tube with parafilm. Vortex the tube (5”) and then place on a rotator (20 min, ~ 
750 RPM). 
11. Spin down the solution (15000 g, 10 min). 
12. Aspirate and discard the supernatant. 
13. Add 0.5 mL of wash buffer. 
14. Repeat 12 – 13. 
15. Resuspend the activated beads in 50 µL PBS. 
16. Add 50 µL of Amine-PEG2-Biotin (200 µg/ml, 100 µg/ml, 50 µg/ml, 25 µg/ml, 12.5 µg/ml, 
6.25 µg/ml  in PBS). This concentration will be adjusted after analyzing the Bradford 
test. 
17. Seal the tubes with parafilm. Vortex the tube (5”) and then place on a rotator (2 h, ~ 750 
RPM). 
18. Spin down the solution (15000 g, 10 min). 
19. Aspirate and keep the supernatant for quantifying unreacted Amine-PEG2-Biotin. 
20. Add 0.1 mL of 1x PBS. 
21. Repeat 19 – 21. 
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22. Resuspend the activated beads in 90 µL PBS. 
23. Add 10 µL of the Glycine solution. 
24. Seal the tube with parafilm. Vortex the tube (5”) and then place on a rotator (1 h, ~ 750 
RPM). 
25. Repeat 11 – 12. 
Resuspend the conjugated beads in 250 µL PBS. Seal the tube with parafilm. Store the stock at 
4ºC. 
To confirm the presence of biotin on the beads, they were incubated with fluorescently 
labeled streptavidin (Thermofisher, Catalog # SA1001) for 2 hours at room temperature. After 
discarding the aspirate, the beads, suspended in 1x PBS, were analyzed in a flow cytometer. Fig. 
4.3b shows the fluorescence intensity of six populations of beads that were prepared.  
The absolute concentration of biotin on the surface of the beads was also determined by 
measuring the unreacted biotin in the aspirate. The number of molecules consumed in the 
reaction was divided with the number of beads to get an estimate of average biotin molecules 
on each bead. Estimated average number of biotin molecules is divided by the surface area of a 
bead to get the surface density of biotin (mr). We made 6 populations of beads with mr = 0.8 x 
1017/m2, 1.1 x 1017/m2, 2.4 x 1017/m2, 5.9 x 1017/m2, 10.5 x 1017/m2, 14.6 x 1017/m2. The number 
of biotin molecules consumed in the reaction was determined by subtracting the unreacted 
molecules from the total number of molecules supplied at the start of the reaction. The number 
of unreacted molecules was estimated by using the Fluorescence Biotin Quantitation Kit 
(Thermofisher, Catalog # 46610). The standard curve for estimating the biotin concentration in 
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the solution is shown in Fig. 4.4a. The mean fluorescent intensity varies linearly with the mr (Fig. 
4.4b). 
Experimental Scheme: Hydrodynamic Focusing & Circular Geometry of Pillars 
Since the shear stress determines the probability of capture, it is necessary that all the 
beads experience identical stress. Moreover, for mathematical tractability, the shear 
stress experienced must be predictable along the length of the channel. The experiment was so 
designed that it fulfilled the above two conditions. 
Hydrodynamic Focusing 
In a microchannel whose height is many times that size of the bead, the primary cause 
of the variability of the shear stress experienced by the beads on the pillars would be due to the 
variation in the vertical position of the bead in the channel. To ensure consistency, all the beads 
were brought to a uniform height in the channel by fluidic means.[81] Fig. 4.5a shows the 
schematic of the microchannel. Fig. 4.5b shows the microscopic image of the microchannel. 
Beads are injected from port A. Fluid injected from port B, C1, and C2 (partially visible) focuses 
the beads in the vertical direction.  The flow rate is adjusted such that all the beads to the mid-
point of the channel. The hydrodynamic focusing is simulated in COMSOL, where it is assumed 
that the height of channel A, C1 and C2 are very small as compared to channel B so that the 3D 
problem could be converted into a 2D problem. Now all the beads are confined in one plane 
and do not experience variation in shear stress due to the vertical location in the channel. 
Moreover, since all the beads are in one horizontal plane, they can be imaged more 
consistently.  Fluid injected from ports D1 and D2 (partially visible) focus the beads laterally. 
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The flow rate of A was 1 μl/min, B was 6 μl/min, C1 & C2 was 3 μl/min, D1 and D2 was 6 μl/min. 
The height of channel A, C1, C2 is 15 µm while that of channel B, D1, D2 is 60 µm. 
Pillar Arrangement 
A precisely designed cyclic arrangement of pillars ensures the beads experience a 
predictably repeating dislodging force. Fig. 4.1c shows the top view of the capture region. The 
gap, g, between two pillars is 14 microns, and the pattern repeats every 3 rows. Motion in such 
a cyclic geometry depends only on the size of beads. 7 micron sized beads (particle 
diameter/gap ratio of 0.5) travel in "zigzag" mode[21] following a cyclic procession of 
streamlines and made contact with the pillars every 3 rows. Hence, Δx = 3 x (14+30) micron 
=132 micron. Because the motion of beads is cyclic, shear stress experienced by the beads is 
cyclic too. 
Channel Fabrication 
The mold was made of SU8 by the conventional lithography technique. The microfluidic 
channels were made in PDMS by using standard soft-lithography. Full protocol for channel 
fabrication has been described elsewhere[38]. 
Surface Modification 
Neutravidin Functionalization: For bead capture experiments, channels were incubated 
with 100 µg/ml neutravidin (Thermofisher catalog # 31000) and stored at 4o C overnight to 
functionalize PDMS with neutravidin.[84] Before the experiment, chips were incubated with 1% 
BSA (Thermofisher catalog # 31000) for 1 hour at room temperature to block non-specific 
interaction. After each incubation step, chips were washed by flowing 100 µl 1x PBS. 
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BSA Functionalization: To prevent non-specific binding, the channel was incubated with 1% BSA 
for 1 hour at room temperature to block any interaction. To remove the unreacted molecules, 
chips were washed by flowing 100 µl 1x PBS. 
Data Acquisition and Analysis 
Bead capture experiment was performed by using beads and flow rates described above 
in microfluidic channels functionalized with neutravidin. A total of 20000 beads were injected in 
the channel for each experiment. All bead populations were assayed in triplicates. After the 
bead capture experiment, the still images of the channel were acquired with a 10x objective. 
Under this magnification, 24 images were required to cover the area where beads were 
captured. The images were then stitched together, and the physical location of each bead was 
determined using a custom written macros in FIJI [85]. The coordinates of beads so obtained 
were exported to an excel file for further analysis in MATLAB[86]. 
To record the trajectories of beads around the pillars, the beads in the buffer were 
injected at flow rates described above in a channel blocked with BSA. The motion of beads was 
recorded at 2000 frames/sec using a high-speed camera (Vision Research Inc., Phantom v310). 
To extract the coordinates of beads in each frame of the movie, a macro was written in FIJI. The 
coordinates of all the beads in all the frames were exported to an excel file for further analysis. 
We used the particle tracking code developed by John Crocker and Eric Weeks[87] in MATLAB 





Shear Stress Estimation using COMSOL Simulations 
We used COMSOL 5.1 to simulate the hydrodynamic focusing of particles and estimate 
the shear stress in the channel. All the simulations were performed in the Microfluidics Module 
using appropriate boundary conditions.  
RESULTS 
Shear Stress (τ) Vs. θ 
Shear stress (τ) is an important parameter affecting the capture of particles in a 
microfluidic channel. Fig. 4.6 shows the τ as a function of θ. Shear stress is highest at θ = ±90o 
and the lowest at 0o and 180o. Therefore, at θ = ±90o, the probability of capture is the least.  
Precise Channel Design Ensures the Predictable Path of Beads 
We designed the pillar geometry in such a way that the beads travel along a predictable 
path in the channel. Fig. 4.7a shows the sign convention followed to describe the angular 
location  around a pillar. Fig. 4.7b shows the trajectory of three beads tracked in a channel 
which was coated with BSA to prevent any non-specific interaction. Therefore, the trajectory is 
independent of mr. We observe that although the beads are displaced slightly on either side 
cyclically, they travel straight on average[78]. The trajectory of the bead is cyclic, and it repeats 
after every three rows (Supplementary movie 2).  
Fig. 4.7b (right) shows the magnified view of the trajectory of one bead around a pillar. 
The blue circle represents the position at which the bead makes the first contact with the pillar. 
We call the angle at which the bead collides with the pillar as the ‘collision angle.’ After 
that, the bead slides around the pillar, while still maintaining contact, until it reaches the 
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position denoted by the orange circle. Here, the bead detaches from the pillar. The angle at 
which a bead detaches from the pillar is called the 'detachment angle.' Fig. 4.7c shows the 
experimentally obtained histogram contact angle and the detachment angle. It has been 
normalized such that the height of each bar represents the fraction of total beads that either 
make contact or breaks contact in a 10-degree bin-width.  
At any given angle, the fraction of particles in contact is denoted by . For  > 0°, the 
number of particles in contact (N) is calculated by subtracting the cumulative sum of the 
number of beads that have detached from the cumulative sum of the number of beads that 
have collided between 0° and θ. For   < 0°, N is calculated by subtracting the cumulative sum 
of the number of beads that have detached from the cumulative sum of the number of beads 
that have collided between θ  and 0°.   is equal to N divided by the total number of beads. Fig. 
4.7d shows  as a function of . 
We assume that the trajectory of beads in a channel functionalized with neutravidin is 
not significantly different from that observed in the channel coated with BSA. This assumption 
is reasonable as, given the diameter of pillars, the gap between pillars and horizontal shift 
between two adjacent rows of pillars, the streamline followed by a bead is a function of size 
only.[88] As a result, the collision angle histogram will stay the same regardless of 
the molecules present on the pillar. The histogram of the detachment angle is expected to 
slightly shift towards θ = ± 180° as the beads would tend to stay in contact longer due to 




The Interplay between Collision Angle and Shear Stress Determines the Angular Capture 
Location 
Figure 4.8 shows the histograms of the angles at which beads are captured on the pillars 
for different values of mr. The histogram has been normalized such that the height of the bar 
represents the fraction of total beads that were captured in 10o bin widths. We have 
considered only those pillars which captured just one bead. This eliminates the interference of 
an already captured bead in the angular location of the said bead. As mr increases, the 
histogram spreads out with the emergence of local maxima at θ = ± 45o, pointed at by arrows in 
Fig. 4.8c, 4.8d, 4.8e, 4.8f. In contrast, the maxima in Fig. 4.8a, 8b is at θ = 0o. This shift in the 
most preferred location of capture can be explained by the competing effects of shear stress 
and that of the collision angle.  
For mr = 0.8 x 1017/m2 and 1.1 x 1017/m2, we hypothesize that the probability of capture 
outside the region |θ| < 10o, due to high shear stress (see Fig. 4.6), is negligibly low. Even 
though the chance of bead making contact with a pillar in region |θ| < 10o is extremely low (Fig. 
4.7d), more than 90% of beads are captured here. Because of the chance that the beads will 
touch the pillar in the region |θ| < 10o is low, beads have to travel very long distances in the 
channel before they collide with the pillar at an angle where shear stress is conducive for 
capture. Consequently, capture events are expected to be rare and spread far apart. This 
hypothesis will be verified in the next section.  
As mr increases, the probability increases that a bead will be captured at an angular 
location where it first makes contact with the pillar. A significant fraction of beads collides with 
the pillars at θ = ±45o (Fig. 4.7c). This explains local maxima in Fig. 4.8c, 4.8d, 4.8e, 4.8f at θ = 
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±45o. Maxima in Fig. 4.8f at θ = ±135o can be explained as follows. If a bead is not captured in 
the region |θ| < 45o, shear stress between 45o and 135o seems to be too high for the beads to 
be captured. However, the shear stress falls dramatically as the bead approaches θ =135o (Fig. 
4.6), and it is captured again.  
Effect of Flow Rate on Angular Capture Location and Spatial Capture Profile  
Increasing the flow rate and decreasing mr reduce the probability of capture (Equation 
4). Hence, increasing the flow rate or decreasing mr are expected to have similar effects on the 
histogram of capture-angle. Upon increasing flow rate for beads with mr=14.6 x 1017/m2, the 
relative prominence of beads captured at θ = ±45o decreases compared to the beads captured θ 
= 0o (Fig 4.9a and 4.9b). We would like to point out that the 10° bin-width does not have any 
physical significance. We choose 10° bin width so that the trend of capture angle histograms 
with increasing mr is easily observed.  
Fig. 4.10 shows the microscopic images of microchannels in which beads with mr=14.6 x 
1017/m2 were injected left-to-right at 49 μL/min (Fig. 4.10a) and 25 μL/min (Fig. 4.10b). At a 
lower flow rate, a greater proportion of beads are capture towards the left.  The shift in the 
cumulative fraction of beads is visible in Fig. 4.11a. The probability of capture, ε, as a result, is 
higher (Fig. 4.11b). 
Spatial Profile of Captured Beads can Determine the Surface Density of Biotin 
Figure 4.12a and 4.12b show the spatial profile of beads with mr = 1.1 x 1017/m2 and mr 
= 14.6 x 1017/m2 respectively captured in the channel. We observe that the number of beads 
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captured per unit length gradually decreases along the direction of the flow of beads. A 
systematic study revealed that mr substantially affects the spatial profile. 
To quantify this influence, we extract the probability of capture per interaction with a 
pillar, denoted by ε, from the experimentally acquired profile of captured beads. This is done by 
fitting theoretically expected capture profile (Equation 5) to the experimental data observed 
fraction of beads captured in the channel (γ, Fig. 4.13a)). As predicted by Equation 5, ε 
increases linearly with mr (Fig. 4.13b, R2=0.99). Therefore, the surface density of biotin 
molecules can be accurately determined by analyzing the spatial profile of captured beads.  
We hypothesized in the previous section that bead capture would be spread far apart for beads 
with lower mr. This hypothesis is verified in Fig. 4.4b. Note that γ increases slowly for mr= 0.8 x 
1017/m2 compared to mr= 14.6 x 1017/m2. According to Equation 4, the probability of capture 
decreases with an increase in flow rate. This is reflected in the decrease in the value of ε when 
the flow rate increases (Fig. 4.11b). 
CONCLUSION 
Although this technique for measuring surface density has been demonstrated with 
beads, we believe that it could be applied to the measurement of antigen expression on cells 
too, for example, measurement of CD64 on neutrophils. To take into account the variability in 
size of neutrophils, the channel has to be designed in such a way that all the cells of interest 
travel in a straight line. For example, neutrophils’ size varies between 10 – 15 microns, so that 
the gap between adjacent pillars should be set 20 - 26 micron so that they travel in ‘zigzag’ 
fashion11. Since we are low Reynolds number regime, we do not expect physical parameters 
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other than sizes, such as deformability or morphology, to affect the antigen expression 
measurement.  
It is a well-known fact that antigen expression varies within a cell population. However, 
a limitation of this technique is that it measures only the mean surface density of molecules of 
cells. In a cell population with varying antigen expression, the profile of captured cells would 
resemble the profile of a cell population in which all the cells express the antigen equal to the 
mean antigen expression in the said cell population. Technical advancements in the technique 
might allow researchers to extract the range of antigen expression in a cell population. 
However, for diagnostic purposes at point-of-care, mean antigen expression on cells, like CD64 
on neutrophils, still provides valuable insight into the disease state of a patient.  
We presented a microfluidic technique that can be used to measure the antigen 
expression or surface density of molecules on particles. We began with a geometry of pillars in 
which beads travel predictably, and its trajectory repeats every three rows. Next, we saw that 
angular distribution of captured beads around a pillar broadens as the surface density of biotin 
increases. This signaled that the capture of beads is affected progressively more by collision 
angle as compared to shear stress. Next, we observed that the spatial profile of the captured 
beads is strongly affected by the surface density of biotin molecules. From this spatial profile, 
we extracted the probability of capture per collision, ε, which predicted the surface density of 
biotin accurately (R2 = 0.99). Although this technique has been demonstrated with beads, it can 
just as easily be extended to cells. It is easy to implement as it requires commonly available 
laboratory instruments such as syringe pumps and a bright-field microscope or a cell phone 
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camera. Hence, this technique can prove to be an inexpensive, rapid and, label-free way to 























Figure 4.1. a) Schematic of the microfluidic channel showing hydrodynamic focusing of beads in 
fluid stream A by buffers in fluid streams B, C1, C2 (not visible), D1, D2 (partially visible). Buffer 
in streams B, C1, C2 focuses the beads in the vertical direction. The buffer in streams D1 and D2 
focus the beads laterally. Beads are captured downstream on neutravidin coated cylindrical 










Figure 4.2. Schematic shows the parameters of the statistical model. The downstream distance 
between two interactions: Δx¸ and number of interactions: n. Particles are injected left to right 





Figure 4.3. a) Reaction scheme used to synthesize beads of varying surface biotin density. The 
surface density of biotin is varied by changing the concentration of Amine-PEG2-Biotin in the 
final step of the reaction. b) Biotin surface density of six populations of beads is quantified by 




Figure 4.4. a) The absolute surface density of biotin on the beads (mr) correlates linearly with 
the mean fluorescence intensity calculated (MFI) in Fig. 3b. The error bars show the mean and 
standard deviation for 3 independent trials of the measurement of Mean Fluorescence Intensity 




Figure 4.5. a) Schematic is showing various fluid streams that were used for hydrodynamically 
focusing beads in the chamber. b) Top view of the microfluidic channel showing various fluid 




Figure 4.6 Plot shows the variation of shear stress (τ) with angle (θ) for two flow rates, 25 





Figure 4.7. a) Schematic shows a pillar concerning the fluid flow. Black arrows show the sign 
convention used for describing angular locations b) Figure shows a subset of particles tracked in 
the channel with a high-speed camera. The inset shows the zoomed given a pillar. The angular 
location at which a bead makes the first contact with the pillar is called ‘collision angle’ (shown 
by the blue circle). The angular location at which a bead detaches from the pillar is called 
‘detachment angle’ (show by orange circle) c) Figure shows the experimentally obtained 
histogram of collision angle and detachment angle. The histogram has been normalized such 
that the height of each bar represents the fraction of total beads either colliding or detaching in 
a 10° bin width. d) Figure shows the experimentally calculated fraction of particles (δ) in contact 





Figure 4.8. The interplay between shear stress and collision angle determines the angle at 
which the beads are captured. Figure shows the normalized histogram of capture-angle for six 
populations (a)-f)) of biotinylated beads. To eliminate steric effects of already captured, only 
those pillars were included in the analysis which captured only one bead. Beads having a low 
surface density of biotin (mr = 0.8 x 1017/m2) are captured exclusively around θ=0°. This 
indicates that bead capture is dominated by shear stress effects. Local maxima of capture-angle 
at ± 45° (pointed at by arrows in c), d), e), f)) becomes progressively more prominent with 
increasing mr. It coincides with the maxima of collision-angle in Fig. 6c. This indicates that as mr 








Figure 4.9. The figure shows the normalized histogram of capture-angle at two flow rates. With 
the increase in flow rate, the relative prominence of peaks at θ = ±45° decreases with respect to 









Figure 4.10. Microscopic image of the channel showing the bead-capture profile at two flow 
rates a) 49 μL/min, and b) 25 μL/min. Beads were injected left to right. When flow rate 







Figure 4.11. a) Plot shows γ as a function of x for two flow rates 25 µl/min (τθ = 90° = 1.9 Pa) and 
49 µl/min (τθ = 90° = 3.7 Pa) for beads with mr=14.6 x 1017/m2. b) Figure shows ε for two flow 






Figure 4.12. Microscopic image of the channel showing the bead-capture profile for beads with 
different biotin surface densities a) mr = 1.1x1017/m2, b) mr = 14.6x1017/m2. Beads were injected 






Figure 4.13. a) Figure shows the fraction of captured beads, γ, as a function of the channel 
length, x, for six populations of beads tested in this study. We extract ε from these curves by 
using least square fitting.  b) The figure shows the variation of the probability of capture per 
encounter, ε, as a function of biotin surface density (mr). ε has a high linear correlation (R2 = 




CHAPTER 5: SMARTPHONE-IMAGED, MICROFLUIDIC TECHNIQUE FOR MEASURING CD64 
EXPRESSION FROM BLOOD 
 
INTRODUCTION 
In this chapter, we present a smartphone-imaged assay to measure CD64 expression on 
neutrophils that does not require RBC lysis. First, we characterized the resolution of the mobile 
microscope and calibrated our set-up against a benchtop microscope. Second, we measured 
the surface density of biotin on beads using the principle described earlier [80]. Third, we 
measured the nCD64 from the whole blood of patient samples. Briefly, whole blood was 
injected in a microfluidic capture chamber, which has a staggered matrix of pillars coated with 
anti-CD64 antibody (Fig. 5.1a). Neutrophils were immunologically captured on these pillars. 
Samples with neutrophils that highly express CD64 travel a shorter distance before getting 
captured as compared to samples in which neutrophils express a lower level of CD64. The cells 
were labeled with a nucleic acid stain and imaged with the smartphone set-up. We developed a 
statistical model to extract the probability of capture when one neutrophil hits one pillar (ε).  ε 
increases linearly with CD64 expression and has a high coefficient of correlation (R2=0.82). We 
also tracked nCD64 of 8 patients (37 blood samples) over time with our technology.  This work 
was done in collaboration with Dr. Hatice Ceylan Koydemir and Prof. Aydogan Ozcan from the 






MATERIALS AND METHODS 
Channel Design 
For measuring ε, whole blood is injected in the chip consisting of a matrix of anti-CD64 
antibody functionalized obstacles (Fig. 5.1b, Fig. 5.1c). The antibody functionalized pillars 
(diameter, d = 30 μm) in the obstacle matrix act as sticky obstacles in the path of neutrophils. 
The probability of neutrophil capture on a pillar increases with increasing nCD64[74]. Assuming 
the downstream distance between interactions with pillars in the obstacle matrix to be Δx, the 
cumulative fraction of cells captured in the chamber (γ) varies with distance, x, as[80]: 
  = − −1 (1 )
x
x                                                                                                                                (6) 
Variation of cell fraction with distance is obtained experimentally by imaging the chip 
with the smartphone set-up. Equation 6 is fitted to the distribution of captured cells in the 
channel to obtain ε. 
A key assumption in Equation 6 is that Δx is constant. To satisfy this assumption, we 
analytically calculated the distance between two pillars (g) in the same row such that this 
assumption holds true during the experiment[78, 80]. In the obstacle matrix, each row is shifted 
laterally with respect to the previous row by a distance equal to a third of the center-to-center 
distance between pillars in the same row, giving rise to a cyclic spatial geometry of pillars. In 
such a cyclic geometry, g = 18 μm leads to consistent Δx throughout the channel for 
neutrophils, which are about 10-12 μm in diameter, with Δx = 3 (d+g) = 144 μm.     
To facilitate imaging, cells were passively brought in one plane. The obstacle matrix is preceded 
by a sedimentation serpentine. The white blood cells slowly sedimented in the sedimentation 
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serpentine under the effect of gravity as they flowed through it. It was determined that the 55 
μm tall channel, which is 225 mm in length, is sufficiently long for the white blood cells to 
sediment in the flow[90]. 
Microfluidic Channel Fabrication 
The microfluidic channels were made from polydimethylsiloxane (PDMS) (Product no. 
761036, Sigma-Aldrich). The SU-8 mold for making PDMS channels was fabricated using 
standard photolithography techniques (Fig. 5.2a). Briefly, SU-8 50 (Microchem) was spun at 
2200 rpm for 30 s. After soft-baking the wafer at the recommended temperature and duration, 
SU-8 was exposed with UV light at a dose of 400 mJ/cm2. After baking the wafer at the 
recommended temperature and duration, unexposed SU-8 was washed away by developing the 
wafer in SU-8 developer (Microchem). The wafer was hard baked at 150 oC for 10 min on a 
hotplate. The thickness of the SU-8 structure was measured using a surface profilometer 
(Alpha-Step D-500 Stylus Profilometer, KLA Tencor) to be 55 μm. An image of the mold is shown 
in Fig. 5.2c. 
PDMS was mixed with the curing agent with a ratio of 10:1 [w/w] and poured on the SU-
8 mold. After degassing PDMS in a vacuum chamber, it was cured at 60 oC for 2 h (Fig. 5.2b). 
PDMS channels were cut out using a knife and bonded to a glass slide after treating it with 
oxygen plasma. The finished channel is shown in Fig. 5.2d. 
Chamber Functionalization With Anti-CD64 Antibody And Neutravidin 
For functionalization of the chamber with neutravidin, the chamber was incubated with 
100 μg/mL neutravidin solution (Product no. 31000, ThermoFisher) overnight at 4 oC. 
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Immediately before the experiment, the chamber was incubated with 1% BSA (Product no. 
A3059, Sigma-Aldrich) in PBS (Product no. 10010023, Thermofisher) for one hour at room 
temperature. 
For functionalizing the chamber with an anti-CD64 antibody, the chamber was 
incubated with 100 μg/mL anti-CD64 antibody (Product no. MAB1257, R&D Systems) overnight 
at 4 oC. Immediately before injecting blood, the chamber was incubated with 1% BSA  for one 
hour at room temperature[74]. 
Conjugating Biotin to Beads 
Biotin was conjugated to carboxylated beads using the protocol described earlier[80]. 
Briefly, 25 μL beads (Product no. UMDG003, Bangs Laboratories) were incubated with 100 mM 
EDC (Product no. 21346, ThermoFisher) and 50 mM NHS (Product no. 24500, ThermoFisher) for 
20 min. Beads were centrifuged, and the solution was aspirated. 50 μL solution containing 
Amine-PEG2-Biotin (Product no. 21346, ThermoFisher) was put into each tube and incubated 
for 2 hours. The concentration of Amine-PEG2-Biotin was chosen to be 1000 μg/mL, 500 μg/mL, 
100 μg/mL, 50 μg/mL, 10 μg/mL and 0 μg/mL as negative control. Beads were centrifuged, and 
the solution was aspirated. The beads were blocked with 100 uL of 7500 μg/mL glycine solution 
(Product no. G8898, Sigma-Aldrich). The beads were centrifuged and stored in 100 μL 1x PBS. 
To measure the surface density of biotin, 2 μL bead solution from each population was 
incubated with 5 μL Streptavidin-APC (Product no. SA1005, ThermoFisher) for 30 minutes in the 
dark. After washing the beads three times with 1x PBS, the fluorescence of the beads was 





Beads were captured in the obstacle matrix by injecting 1000 beads at 25 μL/min in 
chambers functionalized with neutravidin. Non-specifically captured beads were washed away 
by flushing the channel with 50 μL 1% BSA in PBS at 10 μL/min. The beads were fluorescent and 
did not require a fluorescent label for imaging. 
Patient Selection Criteria 
Patients at high risk of sepsis were identified in the Emergency Department, Carle 
Foundation Hospital, Urbana, IL. By a triage nurse. Blood from consenting patients was 
collected in an EDTA tube. Blood samples were de-identified and stored in a refrigerator until 
they were ready to be run on our chip. 37 blood samples were tested in this study. 
Control nCD64 Measurement 
We used flow cytometry as the gold standard for measuring nCD64 of the blood 
samples. The CD64 antibody solution was prepared by mixing 3 μL CD64-PE antibody (Product 
no. FAB1257P, R&D Systems) with 27 μL 0.5% BSA. 8 μL CD64 antibody solution was mixed with 
8 μL blood and incubated in the dark for 30 min. Red blood cells were lysed by adding 160 μL 
ACK lysis buffer (Product no. A1049201, ThermoFisher) and incubating the mixture for 15 min in 
the dark. After adding 80 μL of 3x PBS to the mixture, the sample was ready to be measured. 
Fluorescence from the cells was recorded using appropriate settings on the flow cytometer (Fig. 
5.8). To account for laser intensity variation of the flow cytometer, the fluorescence of PE-MESF 





Neutrophils were captured in the obstacle matrix by injecting 1 µL whole blood at 1 
μL/min. Non-specifically captured cells were washed by flushing the channel with 50 μL 1% BSA 
in PBS at 10 μL/min. 
Labeling Cells with Anti-CD64 PE Antibody 
To test the specificity of capture, cells were labeled with CD64-PE antibody. CD64 
labeling agent was prepared by mixing 20 μL antiCD64 PE-labeled antibody (Product no. 
MAB1257, R&D Systems) with 180 μL 1x PBS. 20 μL CD64 labeling agent was injected at 1 
μL/min, and the chip was incubated in the dark for 30 min. CD64 labeling agent was washed by 
flowing 50 μL BSA at 1 μL/min. Chips were imaged with an inverted microscope (DMI300 B, 
Leica). 
Labeling Cells with SYTO 16 for Smartphone Imaging 
Cells were labeled with a nucleic acid stain, SYTO 16 (Product no. S7578, ThermoFisher), 
for imaging with the smartphone set-up. First, the captured cells were fixed by flowing 50 μL 1x 
1-step fix and lyse solution (Product no. 00-5333-54, ThermoFisher) at 10 μL/min. The chip was 
incubated for 15 min. This step is optional, and it can be skipped to save time. In addition to 
fixing cells, 1-step lyse and fix solution also lyses RBCs that might be remaining in the channel. 
SYTO 16 working agent was prepared by mixing 2 μL SYTO with 1 mL 1% BSA in PBS. 50 μL SYTO 
16 working agent was injected at 10 μL/min in the chip. The chip was incubated in the dark for 




Smartphone Set-up Design 
We used the Nokia Lumia 1020 as the smartphone for our design because this phone 
has a 41 megapixels camera. The regular camera application of the smartphone allows the user 
to adjust white balance, focus, ISO, and exposure time settings of an image, and capture a high-
resolution raw format image (i.e., DNG, 5360 x 7152 pixels) as well as a low-resolution image 
(i.e., JPG, 1936x2592 pixels) at a single shot. For imaging cells, we used daylight mode for white 
balance and let the smartphone’s camera to find the imaging plane by autofocusing.  ISO was 
set at 100 and exposure time was set at 4 s. For imaging beads, all the settings were the same, 
except that the exposure time which was set at 1 s. 
The design of the smartphone-based microscope is similar to the one that was 
previously used for the detection of waterborne pathogens (Fig. 5.1a, Fig. 5.1b) [91, 92]. We 
changed the existing design of the sample holder with a new design to easily image cells in 
multiple microfluidic channels on a microscope slide. The optomechanical unit is a custom-
designed, 3D printed part on which the optical parts purchased from different vendors were 
assembled. The drawing layout of the unit was designed using Autodesk Inventor and printed 
using a 3D printer (Stratasys, Dimension Elite). The unit includes eight light-emitting-diodes 
(LEDs) (Product no. 516-2800-1-ND, Digikey, USA) to illuminate the sample and excite the 
fluorophores on the cells. These LEDs are powered with two AA batteries. The excited light is 
filtered using a single bandpass filter (Product no. ET470/40x, Chroma, USA) to limit the 
spectrum of the LEDs. The emitted light is detected using the rear camera of the sensor at 
which a long-pass filter (Product no. FF01-500/LP-23.3-D, Semrock, USA) and an external lens (f 
= 30 mm) (Product no. 49-662, Edmund Optics, USA) are butt-coupled. The inner side of 
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the unit was covered with a layer of black aluminum foil (Product no. T205-1.0, Thorlabs Inc.) to 
reduce the amount of auto-fluorescence coming from the prototype material. The optical path 
of light is shown in Fig. 5.3c. 
Smartphone Set-up Characterization 
U.S. Air Force (USAF) hi-resolution target (Product no. 59-152, Edmund Optics) was 
imaged to determine the resolution of the smartphone-imaging set-up. The USAF target 
consists of 51 elements with logarithmically increasing spatial frequency of lines within each 
element. The highest resolvable element determines the resolution of the imaging set-up.  
To calibrate the smartphone-imaging set-up, we compared the count of fluorescent beads 
(Mean Diameter 8 μm, Product no. UMDG003, Bangs Laboratories) imaged to a benchtop 
microscope (Olympus) using 10X objective lens (NA = 0.25) and FITC filter set. We injected 
fluorescent beads in the chips at varying numerical concentrations. The chips were imaged with 
the smartphone-based microscope and a benchtop microscope. 
Extracting Co-Ordinates with the Images 
Images acquired through the smartphone microscope were analyzed to estimate ε. A 
custom image processing algorithm was written to extract the coordinates of cells from the 
images. A sequence of operation is shown in Fig. 5.5. These coordinates were used to generate 
the experimental distribution of cumulative density of cells with distance. Then, the 






Smartphone Image Resolution and Calibration 
Fig. 5.5 shows the image of a USAF resolution target imaged using the smartphone-
based microscope. We see three distinct peaks corresponding to three lines in horizontal and 
vertical elements in Group 6 Element 3. Hence, the spatial resolution of the imaging set-up is 
6.2 μm, which should be sufficient for single imaging cells of size 10-12 μm.   
Fig. 5.6a shows a part of the channel filled with 8 μm fluorescent beads imaged by the 
smartphone set-up. Individual beads are visible in the image. In Fig. 5.6c, we compare the 
number of beads imaged using our smartphone set-up to those imaged using a regular 
benchtop microscope. There is a good agreement between the two counts (y = 0.94x + 5.6, R2 = 
0.99). These data suggest that we can substitute a bench top microscope with our smartphone 
imaging set-up for imaging microfluidic chips. 
Smartphone-Imaged Spatial Profile of Captured Beads Predicts Surface Density of Biotin   
We performed preliminary experiments with biotinylated beads to test our smartphone 
set-up. Beads with a varying surface density of biotin were injected in the channel as described 
earlier. The spatial profile of captured beads was imaged using the smartphone imaging set-up. 
Fig. 5.7a shows the fluorescence histograms denoting biotin density on beads used in the 
experiment. Fig. 5.7b shows the smartphone-imaged profiles of captured beads with distance 
with an increasing level of biotin on the surface. As the biotin surface density on beads 
increases (increasing Median Fluorescence Intensity (MFI)), the cumulative fraction of captured 
beads (γ) increases more rapidly (Fig. 5.7c). The probability of capture (ε) increase linearly with 
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Median Fluorescence Intensity (MFI) and has an excellent coefficient of correlation with it (R2 = 
0.99, Fig. 5.7d). 
Smartphone-Imaged Spatial Profile of Captured Cells Predicts nCD64   
Whole blood samples collected from patients were injected in the chip as described 
earlier to capture neutrophils. After labeling the cells with SYTO 16, the spatial distribution of 
captured cells was obtained by imaging the chip with the smartphone imaging set-up. Fig. 5.9 
shows the spatial profile of captured neutrophils for the entire range of nCD64 obtained in the 
study. Blood was injected from left to right in the channels. As nCD64 increases, the neutrophils 
become more likely to be captured when they hit a pillar. Consequently, the mean distance 
traveled by the captured neutrophils is lesser for neutrophils expressing a higher level of CD64. 
This is reflected in the variation in cumulative cell fraction (γ) (Fig. 5.10a). γ increases more 
rapidly with distance for samples which have higher CD64 expression. After fitting Equation 6 to 
the experimental data, we measured ε. Fig. 5.10b shows the plot of ε Vs. CD64 expression 
measured from flow cytometry. There is a high correlation (R2 = 0.82) between the two 
quantities. Hence, our smartphone-imaged technique can be used for measuring CD64 
expression in blood samples. 
Time Course Measurements of nCD64 by Smartphone 
To obtain nCD64 from a smartphone, we performed threefold cross-validation with 
1000 random sample selection on the ε and control nCD64 (data from Fig. 5.10b). nCD64 
measurements in Fig. 5.11a have been color-coded to denote patients they are derived from. 
nCD64 measured by smartphone shows a good agreement with the control measurements (y 
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=0.99x + 0.07, R2=0.82; Fig. 5.11a). Fig. 5.11b shows the Bland-Altman analysis plot. Except for 
one data-point, all measurements fall between two standard deviations of the mean difference 
(with the control measurements). With our technology, we tracked the nCD64 level in 8 
patients admitted to the hospital. Fig. 5.12 shows the nCD64 measured for different patients 
since they were admitted to the hospital. Patients A, D, E, F, and H were diagnosed with sepsis 
during their stay in the hospital. Data from these patients are plotted in bold, dashed lines. 
Other essential patient characteristics like patient age, gender, blood culture result are 
tabulated in Table 5.1. 
CONCLUSION 
Rapid and continuous measurement of CD64 expression on neutrophils at the patient 
bedside could be useful in predicting the onset of sepsis as well as monitoring the response of 
patients to medication. In this paper, we have a described a portable, smartphone-imaged 
assay capable of measuring CD64 expression from minute quantities of blood. Our technique 
works with whole blood and does not require any sample preparation whatsoever. We have 
demonstrated that our system is robust by making a standard curve with 37 blood samples, 
covering the range of physiologically relevant CD64 expression. The portable nature of the 
imaging set-up and the simplicity of our assay make it suitable for translating it to a point-of-











Figure 5.1. Assay Overview and Device Schematic a) Schematic illustration of the process flow 
of the assay i) whole blood is injected in the chip, ii) neutrophils expressing CD64 are 
immunologically captured, iii) non-specifically bound cells are washed and captured cells 
labeled with nucleic acid stain, SYTO 16, iv) the chip is imaged using the smartphone-based 






Figure 5.2. Fabricating Microfluidic Chips a) Figure shows the steps of the lithography process 
for making the SU-8 mold b) Microfluidic chips are bonded to the glass slide by activating the 
surface with oxygen plasma c) Image shows the SU8 mold used for making PDMS chips. The 
inset shows the microscopic image of a portion of the obstacle matrix d) Close-up image of the 




Figure 5.3.  Smartphone Microscope a) Schematic illustrates the key elements of the 
smartphone-based fluorescence microscope b) Isometric view of the smartphone-based 
microscope c) A zoomed-in photo of the microscope and a schematic demonstrating the 









Figure 5.4. Identifying Cells from the Images Acquired through the Smartphone Microscope. 
The background is subtracted from raw, grayscale images. Then the images are binarized by 
performing a thresholding operation. Cells in the binary image are identified by using a 





Figure 5.5. Smartphone Microscope Resolution Testing. An image of a fluorescent 1951 USAF 
resolution test chart using the smartphone-based microscope. It shows a spatial resolution of 
6.20 µm (i.e., group 6, element 3 (G6E3) on the test chart). Subplots are showing the pixel 
resolution of the image for the cross sections of (a-a’) and (b-b’) for vertical and horizontal lines 









Figure 5.6. Smartphone Microscope Characterization a) An image of 8 µm fluorescent beads in 
the microfluidic channel acquired using the mobile microscope. Scale bar: 1 mm b) Comparison 
of the bead counts of different samples obtained from a benchtop fluorescence microscope to 
that of our smartphone-based microscope. There is good agreement between the two counts 





Figure 5.7. Measuring the surface density of biotin on beads using a smartphone-based 
microscope a) Histograms showing the fluorescence of streptavidin-APC measured by a flow 
cytometer. The legend shows the measured Median Fluorescence Intensity (MFI) b) 
Smartphone based microscope images of microbeads captured on the microfluidic chip with 
increasing surface density of biotin. Beads are injected from left to right. Scale bar: 1 mm c) Plot 
shows a fraction of beads captured, γ, as a function of distance traveled in the channel, x. d) 
The plot shows the measured probability of capture per collision, ε, versus red fluorescence 




Figure 5.8. Measuring nCD64 by Flow Cytometry a) Neutrophils, monocytes and lymphocytes 
are gated on the Forward Scatter – Side Scatter plot b) Fluorescence histogram showing 




Figure 5.9. Images show the profiles of captured white blood cells with increasing CD64 
expression. Whole blood was injected from left to right. As nCD64 increases, cell capture shifts 




Figure 5.10. Measuring Probability of Capture (ε) Using Smartphone Microscope a) Plot shows a 
fraction of cells captured, γ, as a function of distance traveled in the channel, x. b) The plot 
shows the measured probability of capture per collision, ε, versus nCD64 measured by flow 





Figure 5.11. Measuring nCD64 with a Smartphone Microscope a) Plot compares patient-wise 
nCD64 measured using the smartphone-based microscope to the control measurements 
performed using flow cytometry. There is a good correlation between the two measurements 
(R2= 0.82, y=0.99x+0.07). b) Bland-Altman analysis chart. It shows all but one nCD64 
measurement using the mobile microscope are within two standard deviations of the mean 




Figure 5.12. Time Course Measurements Plot shows nCD64 in patients tracked over time since 
they were admitted to the hospital. Each color denotes a unique patient. Color legend the same 
as Fig. 11a). Patients A, D, E, F, and H were diagnosed with sepsis. Data from these patients are 
























A Male 73 0.55 – 
1.23 





B Male >89 2.60 – 
4.52 
1149 – 2533 Negative - - 
C  Male 84 5.42 – 
5.45 



















TABLE 5.1 CONTINUED 
 















E Male 81 1.54 – 
6.6 





















G  Female 77 0.41 – 
0.84 
444 – 2425 Negative - - 
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TABLE 5.1 CONTINUED 
 






Table 5.1: Patient characteristics including age, gender, nCD64 range, neutrophil count range, 















CHAPTER 6: CONCLUSION AND FUTURE WORK 
 
CONCLUSION 
Despite the availability of antibiotics, sepsis claims more lives in the United States than 
AIDS, breast cancer and prostate cancer combined [1]. The reason behind this grim reality is the 
lack of a technique that can diagnose sepsis in its early stages. The condition of a septic patient 
deteriorates rapidly with survival chances decreasing by 7% for every hour the appropriate 
medication is delayed [2]. Unfortunately, the current standard for diagnosis, through cell 
culture, can take as long as 96 hours to recommend medication, which is sometimes too late 
[3]. Early diagnosis would mean timely administration of medication, thereby improving patient 
outcome. Measuring biomarkers in blood provide a route to diagnose sepsis early. Elevated 
concentrations of serum protein such as procalcitonin (PCT), IL-6, MMP-9 and the elevated 
expression of CD64 on a neutrophil membrane (nCD64) have been linked to the onset of sepsis 
[4]. Measuring these markers at the patient's bedside frequently, perhaps every 30 minutes, 
would alert the doctor the moment the symptoms of sepsis appear. However, measuring these 
biomarkers in a single assay is challenging because of the size difference of the biomarkers in 
question. A PCT molecule, freely floating in serum, is 5 nm in size whereas a CD64 molecule is 
present on the membrane of a neutrophil 10 microns in diameter - a size difference of two 
orders of magnitude. As a result, a single detection modality has not been used to measure 
both biomarkers. Therefore, even when assays to measure cellular and serum biomarkers 
separately exist [5, 6], simultaneous measurement remains elusive. Deploying such a device in 
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the hospitals alone would save millions of lives every year, and ease a 20 billion dollar burden 
to the US healthcare system. 
In this thesis, we presented miniaturized techniques for measuring these cellular and 
serum biomarkers. In Chapter 2, we presented an integrated electrical system for measuring 
surface density of biomolecules, viz. nCD64 and biotin. We optimized key elements of the 
differential immune-assay, i.e., the on-chip coulter counter and the immunocapture chamber. 
We presented a novel optical immunocapture assay to measure the surface density of biotin on 
beads in Chapter 3. In Chapter 4, we optimized a smartphone imaging set-up to measure nCD64 
from whole blood. 
FUTURE WORK 
Simultaneous detection of one serum and one cellular biomarker from blood will be a 
giant leap forward towards multiplexed detection of biomarkers needed for diagnosing sepsis 
at point-of-care. The objective of the future work would be to develop a smartphone-
compatible microfluidic assay to measure nCD64 and [PCT] at point-of-care. To attain this 
objective, we will develop a PoC device for imaging the spatial profile of immunologically 
captured beads in a microfluidic channel correlates with the average PCT surface density on the 
beads, thus indirectly measuring the [PCT] in the sample. Our approach will be similar to the 
approach we followed for measuring the nCD64 presented earlier. First, we perform an on-chip 
ELISA on magnetic beads. The amount of biotin on the beads will reflect the number of PCT 
molecules. We will also tag the cells with the biotinylated anti-CD64 antibody. Here too, the 
amount of biotin on the cell surface will be indicative of the number of CD64 molecules. 
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Second, we will inject the beads and cells through two channels functionalized with 
streptavidin. The schematic of the integrated device is shown in Fig. 6.1. The first capture 
chamber will be functionalized with neutravidin to capture beads. The images of this channel 
can be used to measure [PCT]. The second channel in series is functionalized with the anti-CD64 
antibody. This would lead to the capture of cells. Cell capture density from this channel can be 
used to measure nCD64 in the sample. Our preliminary data shows that the biotin density on 
beads after performing the immuno-assay is in the same range of biotin densities we measured 
in Chapter 4 (Fig. 6.2). 
This assay will serve as a stepping stone to the development of a multiplexed assay 
capable of measuring multiple serum and cellular biomarkers for diagnosing sepsis. The 
proposed research can have a dramatic impact on the diagnosis and management of sepsis, 













Figure 6.1 Overview of the approach for measuring nCD64 and [PCT]. 100 microliter whole 
blood in incubated with i) anti-PCT antibody conjugated beads ii) biotinylated secondary 
antibody to prepare the ELISA sandwich on-chip. After that, the mixture is injected in chambers. 
[PCT] is functionalized with neutravidin and anti-CD64 antibody connected in series. [PCT] can 











Figure 6.2 Histogram shows fluorescence of anti-PCT antibody-coated beads incubated with 
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APPENDIX A: SUPPLEMENTARY MOVIES 
 
Supplementary movie 1 is saved as a .mp4 file. It shows the beads flowing in a capture 
chamber with row-shift-fraction = 0.5.  
Supplementary movie 2 is saved as a .mp4 file. It shows the beads flowing in a capture 
chamber with row-shift-fraction = 0.33. 
 
 
